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1.1 Problem Statement and Thesis Aim 
Skeletal defects present a major clinical challenge with over 5.5 million fractures 
and 1 million bone grafting procedures done each year 1.  Present clinical skeletal defect 
therapies, such as allogenic bone transplantation and non-bioactive material implantation, 
have limitations 2-6.  This reality points to the need of novel cell-based strategies that can 
be tested in 3D in-vitro models and validated in-vivo. 
Employing strategies that increase the rate of bone formation and enhance 
distribution of osteogenesis may help overcome these limitations 7-9. Factors that may 
enhance bone formation include enhanced nutrient flux, stress, cell-cell adhesion, cell-
cell communication, growth factors, and cell motility10-22. Designing initial seeding 
strategies that can exploit these factors may enable higher cell differentiation and bone 
formation 23-27.  Alternatively, cells can be altered endogenously to express higher levels 
of a particular protein or transcription factor that enable higher differentiation and bone 
formation.  
The aims of this thesis and underlying studies are therefore (1) to employ 
exogenous strategies that can alter bone regeneration and differentiation by virtue of the 
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biomimetic nature of the scaffold and initial seeding conditions that enhance nutrient flux, 
stress, cell-adhesion, cell-cell communication, with an emphasis on gap junction 
intercellular communication (GJIC) and (2) To endogenously overexpress the gap 
junction forming protein Cx43 in bone marrow stromal cells and measure the impact in 
GJIC, cell differentiation, and bone regeneration in 3D, along with the impact of higher 
GJIC when cells are stimulated with the bone osteogenic factor BMP7.  
The following sections present the background relevant to this thesis, finalizing 
with the outline of the content presented in the same.  
 
1.2 Cell-based Constructs 
A cell-based approach 28, 29in which a porous, 3-dimensional synthetic construct 
provides a substrate for cells can enhance cellular growth, proliferation, and provide a 
temporary template for the formation of extracellular matrix and new tissue 30-33.Poly(a-
hydroxy acids) such as poly(lactic acid) and poly(glycolic acid) are considered 
biocompatible and degrade over controllable time scales into natural metabolites, which 
makes them attractive materials for scaffolds 34.  PLGA (polylactic glycolic acid) 
supports osteoblast attachment and growth, in vivo and in vitro 35.  
A suitable cell type can be found in the bone marrow stroma , which consists of a 
heterogeneous population of cells that provide the structural and physiological support 
for hematopoetic cells 36.  The stroma contains cells with stem-cell like characteristics 
called Bone Marrow Stromal Cells (BMSC).  These cells have the potential to 
differentiate into osteoblasts, chondrocytes, adipocytes, fibroblasts, and hematopoetic 
cells 36. BMSCs are a heterogeneous mixture of cells isolated from bone marrow aspirate 
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which adhere to tissue culture plastic. They contain a subpopulation of mesenchymal 
stem cells capable of differentiating into specific tissue, given the proper biological cues. 
However, in-vivo transplants of BMSCs and other cells used to regenerate tissue 
engineered bone, exhibit deficiencies in formation as the inner core of the ossicles lacks 
the nutrient transport necessary to thrive 7, 37, 38. Several important considerations must be 
taken into account to improve the initial conditions of the cell-scaffold construct.  Cell 
seeding and cell-substrate adhesion properties are of paramount concern.  Cell seeding 
conditions control the initial number of cells seeded and the localization of these cells.  
Cyclic seeding conditions, such as filtration, may enhance adhesion because cells have 
the opportunity to adhere several times.  Cell-substrate interactions are important because 
they determine the adhesion affinity, and may promote important signaling cascades.   
In order to form tissue equivalents, cells must be properly seeded into porous 
scaffolds.  These seeding conditions may dictate the ultimate properties and direction of 
the new tissue.  Static or gravitational seeding is the most commonly employed means of 
entrapping the cells in the scaffold 27, 39.  However, this method has inherent limitations in 
cell retention and localization. In rigid scaffolds, cells usually attach at very low 
percentages and show dispersed localization, producing large variability in the resulting 
engineered tissue24, 40.  Furthermore, the ability for cells to adhere into the substrate is of 
pivotal importance.  When cells attach to the substrate in high numbers, higher cellular 
coverage inside the scaffold is possible. Also, as cells attach expeditiously, they can start 
the biological processes and signaling that will lead to proliferation, migration and 
differentiation 9, 26.   
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1.3 Seeding Strategies and Template Chemistry for 3D tissue engineered 
constructs 
To address the seeding density and localization problem, an alternative method of 
seeding can be done by filtering the cells into the scaffold in a cyclic manner.  This 
method circulates the cell suspension through the scaffolds, with a small pressure 
gradient applied by a peristaltic pump. The homogeneous cell suspension that filters 
through the scaffold is cycled through and may produce higher cell density and even 
cellular distribution.  The increased cell density, nutrient flux and sheer stress point to the 
potential of producing higher cellular adhesion and lower variability among samples 21-
23. As an added benefit, the oscillatory flow gradient increase proliferation and 
differentiation in BMSCs 41, 42.  
A higher density of cells is desired to increase the cell-cell contacts that enable 
cellular communication and signaling.  However, such high densities may produce an 
adverse microenvironment due to a supersaturation of cells inhibiting transport39.  Passive 
nutrient diffusion is one of the biggest obstacles in 3D cell-scaffold composite systems 43.  
Particularly for bone, the outer layer of cells and tissue prohibits proper exchange of 
nutrients and byproducts inside the ossicle’s core. One way to bypass this is by seeding 
cells in dense micromasses.  These micromasses are placed in a particular location in the 
scaffold (center), leaving less crowded areas were nutrients can flow through. Micro 
masses could provide the benefits of higher density cell-cell communication, while 
allowing for transport of nutrients and cellular byproducts, as well as migration of cells 
that would enable a differentiation gradient from the core to the periphery.   
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To create a favorable biomimetic environment, a mineralized layer on a PLGA 
scaffold can be a dominant factor for the enhancement of cell adhesion and 
osteoconductivity 44, 45.  The increased adhesion will lead to a higher density of cells in 
the construct which is desired for increased cell-cell communication. This bone like 
apatite can form on the polymer scaffold and mimic physiological conditions by 
incubating it in simulated body fluid (SBF) 34, producing ion concentrations are similar to 
blood plasma.  In this case, the PLGA will function as a bulk material that degrades at a 
controlled rate while the mineral layer serves as a biological interface. Additionally, the 
surface mineralization is expected to provide a bioactive surface to moderate Ca++ flux 
into the cells, for enhanced differentiation, signaling and cellular growth 12, 45-48.  This 
calcium flux is an important cell-cell messenger in osteoblasts that may be important for 
proper bone remodeling and regeneration13, 49.   
These seeding and substrate mineralization approaches exploit the initial exogenous 
physical conditions of the cells and substrate to overcome the incomplete regeneration of 
tissue.  Alternatively, an endogenous approach to enhance cell-cell communication (gap 
junction intercellular communication) could be employed to overcome some of these 
problems.  
 
1.4 Gap Junctions 
Gap junctions are present in all types of vertebrates, except very few cases such as 
red blood cells platelets, and some neurons 50.  This ubiquity makes it reasonable to 
consider gap junctions a fundamental structure necessary for cell differentiation and 
signal transfer.  Composed of two juxtaposed hemichannels present on the surfaces of 
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adjacent cells, Gap Junctions form a transcellular channel that permits the rapid and 
efficient propagation of ions, metabolites, and second messengers between adjoining cells.  
These hemichannels are called connexins.  Each Connexin monomer is a polypeptide 
consisting of 4 transmembrane domains (two extracellular loops, one intracellular loop, 
and intracellular carboxylic and amino ends).  Throughout different types of tissue, gap 
junctions play a mayor and extensive role in response to mechanical, electrical and 
chemical stimuli51-53.  
Out of the 20 known connexins, only Cx43, Cx45, and, to a lesser extent, Cx46 
have been shown to exist in bone cells54, 55.  The primary gap junction in bone is Cx43 54, 
56, 57.Cx43 produced Gap junctions have been demonstrated between osteoblasts8, 58-62  as 
well as communication between osteocytes and osteoblasts1311, 63. The extensive network 
formed by osteocytes is also dictated by their gap junctions.   
Gap junctions have been found to exist between bone marrow stromal cells64.  
The have considerable consequences in defining the structural organization of the 
hematopoietic environment65.  This opens the possibility that bone marrow stroma can 
receive developmental cues via gap junctions 59.   
Genetic modifications have been made to elucidate the role of Connexin 43 mediated gap 
junctions in different bone forming cell types and mouse models.  Cx43 knockout mice 
have shown delayed ossification and osteoblasts dysfunctions8    Several studies indicate 
that the increase of Cx43 expression either by upregulation or transfection increases GJIC 
66-68,  and have elucidated potential mechanisms of cell-cell communications69-72.   To 
understand the role in bone formation, null mice (Gja1jrt/+) carry a point mutation in the 
Cx43 gene that produces dominant negative properties 73. Cx43 null mice exhibit 
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profound mineralization defects in shape and mineralization of skeletal elements74.  
These mice die pre-natally due to severe defect in the heart leading to swelling and 
blocking of the right ventricle outflow75.   Cells obtained from the cranium of these null 
mice showed delayed differentiation and mineralization76.  In order to understand the role 
of communication through gap junctions in bone cells, Rat osteosarcoma cell line UMR 
has been used as a model to determine the role of Cx43 in cells 8, 77.  These cells are 
characterized for not expressing Cx43, but do in fact express Cx45.   
Gap junctions have been implicated in many important mechanisms in bone 
regeneration such as the regulation of Erk, RankL, Tbox expression, responses to growth 
factors such as BMP-2, and the diffusion of paracrine agents such as PTH 52, 56, 78-80.  A 
generalized mechanism for the gap junctional role of Connexin in bone cells can be 
developed based on the research done on this area (Figure 1).  Our experiments 
investigate the effects of gap junctions when cells are stimulated with a potent 
osteoinductive agent.  
 
1.5 Outline of Thesis Content 
 The coming chapters describe the experiments performed to addressed the aims of 
this thesis.  The second chapter of this thesis contains a preliminary study that was 
performed to validate the micro CT thresholds for tissue engineered bone.  These 
thresholds were used to analyze all in-vivo data in the subsequent chapters.  Chapter 
number 3 addresses the effects exogenous seeding strategies and mineralized template on 
gap junction intercellular communication (GJIC), cell differentiation in 3D constructs, 
and bone regeneration in-vivo.  
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Chapter 4 examines enhancing endogenous cell-cell communication in bone 
marrow stromal cells, by transducing these cells with the most prevalent gap junction 
forming protein in bone, Connexin 43 (Cx43).  Transfection efficiencies, Cx43 
expression and GJIC were quantified to measure the expression level and function of the 
gap junctions.  GJIC is measured and compared in both 2D and 3D cultures, as well as 
cell differentiation.  Furthermore, the distribution of GJIC and differentiation markers is 
quantified, to quantify any differences in these parameters between cells on the surface of 
3D scaffolds and those seeded at the core. To assess the effect of enhanced GJIC on 
tissue engineering in-vivo, cells are transplanted subcutaneously in nude mice, and 
examined for amount and spatial distribution of the regenerated tissue.  The bone 
morphogenetic protein 7 (BMP7) was used to test the effects of higher GJIC along with a 
tissue forming stimulus.   Cells were also transduced with a  7 base pair deletion on the 
Cx43 gene (Cx43∆7), in order to assess the dominant negative effects of Cx43 in GJIC 
both in-vitro and in-vivo (Appendix 17).    
 The final chapter summarizes the important findings and interpretations of this 












Figure 1-1:  Generalized mechanism for the role of gap junction intercellular 
communication in bone cells. 
A primary messenger in the form of a hormone, growth factor, or mechanical stimulation 
elicits a response from the host cell.  This response is the production or influx of 
secondary messengers (e.g cADP, IP3, Ca+2) that enable the activation of a cascade (e.g. 
ERK).  This cascade produces a transcriptional response in the host cell.  The secondary 
messengers produced can modulate the gap junctions to either open or close.  If open, 
these secondary messengers will go through the gap junction channel and elicit the same 
response (as in the host cell) in adjacent cells, without the need for a primary messenger 
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Establishing Micro CT Thresholds for Tissue Engineered Bone and Comparison of 
Bone Regenerated from Bone Marrow Stromal Cells and BMP-7 Transduced Cells 
2.1 Introduction 
To regenerate complex tissues such as bone, a variety of cell types, including 
differentiated cells, progenitor cells and genetically modified cells have been delivered 
from designed scaffolds 1-3.  Bone regeneration from transplanted cells has been 
accomplished in open and closed systems in large and small animals, and human clinical 
trials are underway 4, 5.   Comparison of the quantity and quality of bone regenerated via 
different strategies is lacking, however, in part because standardized means of analyzing 
bone regeneration are lacking. Standard radiographic and histological techniques provide 
a starting point for analysis of regenerated tissue and efficacy of tissue engineering 
strategies6. These techniques are useful, but they cannot be easily used to measure the 
amount of new bone tissue nor the mineral content of that bone tissue in three dimensions. 
The gold standard for accurately measuring the amount of new bone tissue is 
histomorphometry, where two-dimensional sections of a region with the scaffold are 
stained and the amount of new bone tissue is quantified. The gold standard for measuring 
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the bone mineral content is ash weighing.  In this procedure, bone is heated to 
temperatures upwards of 800oC, eliminating organic phases, and the remaining non-
organic weight is measured and normalized to starting weight or tissue volume.  
Although these techniques provide an accurate determination of the amount of mineral 
and the mineral content, their usefulness in analyzing tissue engineering strategies is 
limited because specimens are destroyed in the process eliminating the possibility of 
further molecular and biochemical analyses. 
Micro-computed tomography (µCT) has become an important tool to overcome 
these limitations. This imaging modality has a wide range of biological applications 
including vascular and pulmonary trees, adipose tissue, embryonic development, cartilage 
and hepatic tissue, and it is particularly well suited for bone.7-17. For bone, µCT  provides 
detailed spatial reconstruction of mature  18, 19and regenerated bone 20-23.  These 
reconstructed µCT images can be used to determine bone architecture in three orthogonal 
directions.  The bone volume fraction (BVF) and bone mineral density (BMD) can also 
be calculated using algorithms that are independent of orientation using custom or 
commercially available software.  One concern, however, when performting these 
calculations is separating the bone tissue from the other tissues within the image. This is 
particularly crucial for BVF calculations where care must be taken to accurately 
determine a threshold for the voxel intensity that distinguishes bone from marrow, air, 
fibrous tissue or surrounding scaffold.  
Three thresholding approaches have been employed to solve this problem.  One 
approach employs an autothresholding function that uses the frequency distribution 
(histogram) of voxel values in the images to determine the threshold between two 
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populations. This algorithm assumes that the image has a bimodal histogram, a mid-point 
of the intermodal zone is chosen as the cut-off between bone and soft tissue based on 
optimization of the variance between the two histogram peaks 24.  The second approach 
that has been used for trabecular bone thresholding is local thresholding25, 26.  In this 
approach, the local neighborhood of every voxel within the µCT image is taken into 
account when determining if a voxel is bone. This approach is powerful; however it can 
be complex to implement. Because of this complexity, and because many bone 
regenerative approaches do not have a bimodal histogram (Figure 1), the vast majority of 
tissue engineering studies do not employ these methodologies.  Instead, they use a simple 
global threshold where a single grayscale value is selected and voxels with intensities 
over that number are defined as bone.  Using this global thresholding approach is a 
source of concern because the source of such standardization is unclear and may lead to 
an inaccurate quantification of the amount of bone and, therefore, an inappropriate 
comparison of bone regenerated under different conditions.  
Because of these limitations, the goal of these experiments was to determine a 
global threshold for quantification of volume fraction of tissue engineered bone using 
µCT.  To determine the appropriate threshold, the amount of regenerated bone 
determined via µCT was compared to the amount of regenerated bone determined by the 
more conventional techniques of ashing and quantitative histology.  Regressions were 
performed on three types of data over a range of thresholds to determine the threshold 
that yielded the best fit between µCT data and conventional data.  First, the BVF 
determined from µCT was compared with the ash fraction to compare the amount of new 
bone three-dimensionally. Second, the 2D area fraction of bone determined from µCT  
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and the 2D area fraction determined via H&E staining in a closely aligned histological 
plane were used for visual and quantitative comparisons.  Quantification of bone on H&E 
stained sections can be subject to variation because measurements are dependent on 
subtle changes in the matrix architecture, so von Kossa staining, which has high contrast 
in areas of mineralization, was also employed. The third regression comparison compared 
the 2D area fraction of bone determined from µCT with 2D mineral fraction determined 
by thresholding von Kossa stained histological sections.  In order to make this analysis 
applicable to images obtained using different uCT scanners, the thresholds were 
normalized to the Bone HU value from the hydroxyapatite phantom. This hydroxyapatite 
has a similar radiodensity to mature bone and does not change. Normalizing to this value 
(reported as % Bone HU) reflects the ratio of the threshold radiodensity in comparison to 
the radiodensity of mature bone. After an appropriate threshold was determined, a 
comparative study between the amount and distribution of bone regenerated in-vivo from 
transplanted murine BMSCs and BMP-7 transduced cells was conducted.  
 
2.2 Materials and Methods 
2.2.1 Bone marrow stromal cell isolation and culture 
Five- to eight-week old male C57BL/6 mice were used to isolate bone marrow 
cells from the femoral, tibial and humeral cavities (six bones per animal), as previously 
described 27.  Briefly, bone marrow cells were isolated by extracting the marrow from the 
bone cavities.  The bone marrow was mixed with complete medium (minimum essential 
medium (α-MEM; Gibco Laboratories, Grand Island, NY), 10% fetal bovine serum 
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(FBS; Gibco), 100 µg/ml penicillin G, 100 IU/ml streptomycin).  Cells were pelleted by 
centrifugation at 1000 rpm for 5 min at 4°C and resuspended in 10 ml α-MEM. Cell 
number was determined with a hemocytometer and cells were plated in 75 cm2 flasks at a 
density of 50,000 nucleated cells/cm2 and cultured in complete medium at 37°C in 5% 
CO2/95% air.  The medium was replaced twice per week and at near confluence (~90%), 
the adherent cells were washed with phosphate-buffered saline and released by means of 
a 0.25% trypsin-EDTA solution (Sigma, St. Louis, MO).  Cells were replated in 75 cm2 
flasks at a density of 50,000 cells/cm2 and passaged 1-2 more times.   
2.2.2 Generation of recombinant adenovirus and cell transduction 
AdCMVBMP7 was constructed by Cre-lox recombination, as previously 
described  28. Briefly, a full-length mouse BMP-7 cDNA was cloned into pAdlox to 
produce pAdlox BMP-7.  pAdlox and ψ5 virus were co-transduced into CRE8 cells. A 
plaque assay was used to purify the virus from the cell lysate and serial dilutions were 
used to infect 293 cells.  Positive plaques were purified by CsCl gradient 
ultracentrifugation. The purified virus was stored in glycerol phosphate-buffered saline 
and titered by the method described above. 
Mouse C4 cells, a widely used cell strain from C57L/J mice, from American Type 
Culture Collection (ATCC) were cultured in complete medium at 37°C in 5% CO2/95% 
air. Transduction was performed ex vivo for 24 hrs. C4 cell infection with AdCMVBMP -
7 was at a multiplicity of infection (MOI) of 200 Plaque-forming units (PFU)/cell.  Cells, 
80-90% confluent in 75 cm2 flasks, were exposed to the appropriate dilution of virus in 8 
ml of medium for 24 hrs at 37°C in a humidified atmosphere of 5% CO2 before 
trypsinization, counting, and resuspension in complete medium. 
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2.2.3 Gelatin sponge preparation 
Gelatin sponges (Gelfoam®; Pharmacia & Upjohn, Kalamazoo, MI) were cut to 
have 3×3×2 mm3 dry dimensions. The sponges were pre-wet in complete medium, and 
air bubbles were removed by applying gentle pressure on the sponge between two pieces 
of sterile filter paper. Two million BMSCs or transduced C4 cells were collected, 
suspended in 50 µl complete medium, and loaded onto each sponge by capillary action. 
2.2.4 Preparation of bioceramic (Mineralized PLGA)  scaffold 
Porous, 3D organic templates (85:15 poly(lactide-co-glycolide), diameter = 4mm 
x height = 1mm, 90% porosity, pore size 250-425µm) were prepared by solvent casting-
particulate leaching process. Scaffolds were each be incubated in a 50-mL solution of 
simulated body fluid (SBF) for 7 days for mineral film formation. The SBF solution will 
was changed every 24 h to ensure sufficient ion concentrations for mineral growth. The 
SBF was prepared by dissolving the following reagents in deionized water: 141 mM 
NaCl, 4.0 mM KCl, 0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 2.5 mM CaCl2, 
and 1.0 mM KH2PO4. SBF was buffered to maintain a pH 7.4 with Tris-HCl and 
washeld at 37°C for the duration of the incubation period.  
2.2.5 Transplantation into host mice 
All procedures involving animals were performed in accordance with protocols 
approved by the University Committee on Use and Care of Animals (UCUCA) at the 
University of Michigan.  A total of 60 implants (30 BMSC loaded implants and 30 
transduced cell loaded implants) were transplanted subcutaneously into 15  nude mice, as 
previously described 1.  Briefly, nude mice (nu/nu) were anesthetized by an intraperitoeal 
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injection of 100 mg/kg ketamine and 10 mg/kg xylazine. An incision was made on the 
back of each mouse and implants were inserted into the subcutaneous cavities.  Four 
gelatin/cell constructs (2 BMSC, 2 BMP-7) were placed per mouse and wounds were 
closed with surgical clips.  The location of the constructs within each mouse was 
randomized.  
2.2.6 Micro-CT image acquisition and analysis  
Ossicles were scanned on a high resolution cone beam micro-CT system 
(Enhanced Vision Systems (now GE Healthcare Preclinical Imaging), London, Ontario, 
Canada) while immersed in distilled H2O. The x-ray source voltage and current were 80 
kVp and 80µA, respectively. To reduce the potential for beam hardening artifact, the x-
rays were passed through a 0.2mm Al filter immediately upon exiting the source and the 
specimens were immersed in dH2O during the scanning process. Projection images were 
acquired over 198 degrees using 2x2 binning and an exposure time of 1100 ms, and four 
frames were averaged for each projection to improve the signal to noise ratio. The 
projection data was then corrected and reconstructed using the Feldkamp cone-beam 
algorithm to create three-dimensional images with an isotropic voxel size of 18µm.  The 
scanner was calibrated once daily using a phantom that contained air, water and 
hydroxyapatite.. 
Bone volume fractions were determined by using a MatLab program designed to 
integrate all grayscale voxels above a particular threshold.  To determine the overall 
volume of the ossicles, the program determined the perimeter of each 2D µCT slice by 
tracing the outer edge. The program then integrated all the perimeters to determine the 
3D surface area, and the number of voxels inside the surface defined the total volume.  
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High density voxels outside of the 3D surface and unattached to the ossicle were 
discarded, while voxels inside were evaluated at the specified thresholds to determine the 
BVF, which was calculated as the number of voxels above the threshold relative to the 
total number of voxels.  Bone volume fractions were calculated for all samples at a range 
of thresholds (600-2000, in increments of 100) ,in order to create a library of BVF values 
for regression against ash fraction and histologically determined bone and mineral 
fractions.  % bone HU (threshold/bone HU) was calculated for all of the thresholds, in 
order to make the results applicable to any µCT device. The bone HU (Hounsfiled units) 
was obtained from the calibration scans of actual bone.  Auto thresholds, generated using 
a previously described method that operates on the histogram of all grayscale values 
within the image,24were also recorded for comparison. 
2.2.7 Mineral ashing   
After µCT scanning, 5 ossicles from each group were weighed, placed in a muffle 
furnace at 100ºC for 36 hrs to remove the soft-tissue in the ossicles, and reweighed.  This 
fraction was heated to 800ºC for 48 hrs to obtain the final inorganic weight.  The final 
inorganic weight was normalized to the ossicle weight (without soft tissue) to determine 
ash fraction.   
2.2.8 Histology 
To assist in matching histological sections to µCT slices, a landmark was created 
in each ossicle by making a small cut with a scalpel before it was scanned in the µCT 
system 25  The longitudinal and transverse distances to the landmark from a reference 
point on the surface were recorded to define the approximate location and orientation of 
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the slices of interest, thus making it easier to locate when viewing the µCT and 
histological sections.  After µCT scanning, the remaining ossicles from each group were 
rinsed in dIH2O, dehydrated in graded ethanol, and processed for histology.  Some of the 
specimens were  decalcified in 10% formic acid for 5 days, embedded in paraffin, 
sectioned in 5µm slices, deparaffinized, hydrated, and stained with hematoxylin and 
eosin (H&E).  The remaining specimens remained undecalcified and were embedded in 
plastic, sectioned to 5µm and stained with von Kossa.  For both decalcified and 
undecalcified sections, the first 5µm section below the landmark was used for 
comparison with the first µCT slice below the landmark.  The next 3 serial sections (~ 
50µm apart from each other) were also compared with their corresponding µCT slices for 
thre regression analyses.  Since the histological sections were approximately 50µm apart, 
the maximum distance between the histological  and µCT slices is < 50µm.  Both H&E 
and von Kossa stained slides were photographed and processed blindly with respect to 
treatment group with Image Pro Plus 4.0. A 2D visual alignment followed to subjectively 
compare the histological sections with the analogous micro CT sections.  This approach, 
although not an exact mathematical registration of the images, allows for both good side 
by side visual comparison (Figure 3) and quantitative comparison for the von Kossa and 
µCT data sets. The amount of mineral present in the von Kossa images was set using a 
grayscale selection mechanism relative to a standard (Image Pro Plus 4.0).  The same 
approach was used to compare the actual amount of bone fraction in the H&E stained 
sections with a µCT  slice. Here, bone fraction in the H&E slides was determined by 
careful visual examination of regions where bone was observed.  These selected sections 
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were quantified and the results were stated as a fraction of the complete area of the 
ossicle.   
2.2.9 Analysis of bone ingrowth  
A custom program was developed to determine the distribution of regenerated 
bone as a function of the distance to the geometric center of each ossicle.  Using the von 
Kossa stained sections, the centroid was calculated using a MatLab script  8 and used as a 
frame of reference to divide the ossicles into 4 regions.  Defining the centroid as the 0th 
percentile and the edge as the 100th percentile, boundaries were calculated by lines that 
radially pointed into the center from the edges.  Using the same selection criterion for 
defining mineral as above, the program determined the percent of bone present in regions 
0-25%, 25-50%, 50-75% and 75-100% of the area away from the centroid.   
2.2.10 Statistical analyses 
Linear regression analyses were performed to determine the thresholds with 
highest R2 values and an optimal threshold range for defining de-novo bone.  This 
optimal threshold is defined as a range where R2>0.85. The BVF predicted by µCT was 
regressed against ash fraction over a range of thresholds (600-2000 in increments of 100) 
to determine a volumetric correlation.  Two dimensional correlations were also 
performed over the same threshold range to compare the 2D area fraction of bone 
determined from µCT vs. the 2D area fraction determined via H&E and von Kossa. 
Regressions were performed for each cell type and time independently and by pooling 
cell types and time (SigmaStat 3.1).  Comparisons between mean BVF or area fraction 
and ashing or histology at each threshold were also carried out via t-tests (paired, two-
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tailed).  Because this range of thresholds can vary on different scanners, the ratio of these 
thresholds to the bone HU value was calculated and will be reported in addition to the 
actual grayscale values used.. 
Two way analyses of variance (ANOVA) were used to evaluate effects of time and 
cell type on overall volume, BVF and mineral content.  One way ANOVA on bone 
fraction as a function of cell type and region were also performed.  All analysese were 
performed using SigmaSTAT version 3.1, using Turkey’s HSD post hoc test. Statistical 
significance for all tests was assumed if the p < 0.05.  
 
2.3 Results 
2.3.1 Threshold analysis 
There was no difference in the optimal threshold range (defined as having an 
R2>0.85) between ossicles formed from BMSC and BMP7 transduced cells.  Therefore, 
thresholding results are reported on data pooled from both cell types.  Based on the 
comparison of µCT BVF calculations with ash fraction data, there was a slight difference 
in the optimal threshold with time of implantation (Fig. 2).  At 4 weeks, a threshold of 
1000 yielded the highest coefficient of variation (Fig. 2a), whereas the  threshold with the 
highest R2 increased to 1100 and 1300 at 8 and 12 weeks, respectively (Fig. 2b and 2c).  
The highest R2 for the pooled times occured at a threshold of 1000 (R2=0.9431, Fig. 2d).  
There was no significant difference in the BVF of ossicles calculated at a threshold of 
1000 vs. 1300.  P-values for the regressions in the 1000-1300 range are significant (p = 
0.021, p = 0.042, p = 0.009, p = 0.049, respectively), while those for higher thresholds 
were not significant. 
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Regressions on the quantity of bone determined on 2D µCT slices vs. H&E 
sections had the highest R2 values at a threshold of 1200 for all individual timepoints and 
the data pooled across timepoints (Fig. 3a through 3d).  The range of threshold values 
with high coefficients of correlation (1000-1300) are identical for the 3D comparison of 
µCT BVF to ash fraction data that occur for the 2D comparison of H&E stained sections 
with corresponding planes of the µCT images.  
von Kossa stained sections verified the location of mineral deposition in 2D and 
suggested that ossicles were less dense at the early stages of regeneration than at later 
timepoints (Fig. 4, left panel). This increase in mineral content packing is also observed 
on comparable 2D planes of the µCT images (Fig. 4, right panel).  Regressions on the 
quantity of bone determined on 2D µCT images vs. von Kossa stained sections 
demonstrated the highest R2 values at a threshold of 1000 after 4 weeks and 12 weeks of 
implantation and 1100 after 8 weeks of implantation (Fig. 4).  When the data were pooled 
among timepoints, the global threshold value of 1000 had the highest coefficient of 
variation (Fig. 5d).     
To further ensure that the global threshold range of 1000-1300 on a µCT image 
accurately represents the amount of bone, the data were pooled across timepoints and 
µCT data was statistically compared with the ash fraction and histology data. There were 
no significant differences between the µCT data and the corresponding ash fraction or 
histology data.  When taken in conjunction with the regression analyses, this suggests 
that this threshold range can accurately be used to quantify the amount of bone on a µCT 
image. Therefore, an optimal threshold range was defined as 1000-1300.  
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Autothreshold values show a marked difference (25-48%) from the threshold with 
highest R2 value at 4 and 12 weeks, and this difference was even larger at 8 weeks (Table 
1).  The autothresholds for the 8 week groups were significantly greater (p = 0.0213) than 
those for the 4 and 12 week periods, and had greater variability within each group, even 
though the regressions indicate that the optimal threshold range for the 8 week timepoint 
is similar to the optimal threshold range for the 4 week and 12 week timepoints.  Auto-
thresholds were greater than the optimal threshold range determined by the regressions, 
which would lead to an underprediction of BVF if autothresholds were utilized.  
2.3.2 Comparison of bone regenerated with different cell types 
Both transplanted BMSCs and BMP-7 transduced cells formed self-contained, 
mineralized bone and bone marrow organs (Fig. 6c).  An intact cortical shell of bone 
defined the external boundaries of the ossicles, and the internal portion of the implants 
contained amorphous mineralized tissue (Fig. 6b-6c).  While both cell types supported 
active hematopoesis, bone formed from BMP transduced cells often had small amounts 
of fibrous tissue localized to the central regions of the implant.  Quantifying the amount 
of bone indicated that there was a statistically significant increase in the volume fraction 
of bone regenerated throughout the duration of the study (Fig. 6a). However, there was 
no significant difference in the volume fraction of bone formed between the two cell 
types.   
Variations in the ossicle volume also occurred throughout the study. The ossicles 
derived from BMP-7 transduced cells were consistently larger than ossicles formed from 
BMSCs (p<0.001 for all time points) and significantly larger than the original scaffold 
after 2 weeks (p=0.032). BMSC derived ossicles were small and maintained the size of 
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the original implanted scaffold (Fig. 7A).  Transient differences in the ossicle volume 
also occurred throughout the study. The volume of the ossicles was significantly greater 
in the 12 week group compared to the 4 and 8 week groups in both cell types (BMSC: 
p=0.021 for 4 weeks vs. 12 weeks and p=0.024 for 8 weeks vs. 12 weeks; BMP-7: 
p=0.049 for 4 weeks vs. 12 weeks and p=0.044 8 weeks vs. 12 weeks).  Similar transient 
differences occurred in the ossicle ash content. The ash content was significantly greater 
in the ossicles formed from BMP-7 transduced cells in comparison to ossicles formed 
from BMSCs at all timepoints (p = 0.002, 0.001, 0.021 at 4, 8 and 12 weeks, 
respectively).  The ash content increased significantly after 4 weeks in bone formed from 
both cell types (Fig. 7b; BMSCs: p=0.20 for 4? weeks vs. 8 weeks and p=0.029 for 8  
weeks vs. 12 weeks; BMP-7: p=0.001 for 4? weeks vs. 8 weeks).       
There was also a significant difference in the distribution of bone regenerated by 
the two cell types (Fig. 8).  As observed in the µCT renderings, the ossicles show distinct 
patterns of osteogenesis (Fig. 6b).  The bone regenerated by BMSCs showed significantly 
more bone formation in the periphery (76-100th percentile region) for the BMSCs vs. 
BMP-7 transduced cells (p=0.0198), with light mineral expression in the central part of 
the ossicle.  There was significantly more internal bone regeneration in the BMP-7 
constructs than for the BMSC constructs (p=0.0308 in the 0-25th percentile region and 
p=0.0242 in the 26-50th percentile region)..   
To demonstrate that the thresholds were not specific to the resorbable gelatin 
scaffolds, bioceramic scaffolds, synthesized by the self assembly of carbonated apatite 29, 
30, were also tested.  The volume fraction of bone regenerated from BMSCs transplanted 
on these scaffolds for 6 weeks was analyzed.   Regressions between BVF (calculated as 
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the percentage of voxels above the threshold in the bone/bioceramic composite minus the 
mean percentage of voxels above the threshold in a group of ceramic scaffolds implanted 
without cells) and ash fraction (calculated as the ash fraction of the bone/bioceramic 
composite minus the mean ash fraction of a group of ceramic scaffolds implanted without 
cells) showed that the highest correlation was achieved at 1200 and the range 1000-1300 
exhibited R2 values greater than 0.95 (Fig. 9). 
 
2.4 Discussion 
Micro CT has been extensively used to characterize mature trabecular bone18, 19, 25, 
31, 32  and, more recently, to characterize bone regenerated via a variety of tissue 
engineering approaches  20-23.  , as well as porous scaffolds themselves  33-35.  The 
strength of this technique lies in both the ability to nondestructively image the tissue in 
3D and, more importantly, quantification of the structures within the three dimensional 
image. However, before any analyses can be performed the bone tissue must be separated 
from the marrow, water, air and other soft tissue within the image.  The differentiation 
between bone and nonbone is generally based upon differences in radiodensity. The 
inherent difficulty in this procedure may cause image thresholding techniques to have a 
major impact on the characterization of osteogenesis  19, 25. Because of this, there has 
been an extensive effort to rigorously compare bone morphometric measures from µCT 
images with histological sections for trabecular bone measurements. 19, 36-38Three major 
thresholding approaches have been used to facilitate these comparisons. 
Algorithm based auto-thresholds have been extensively used to delineate bone 
from the other tissues 32.  These methods are statistical in nature, do not segment based on 
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features within the image, and rely on the assumption that the histogram of all grayscale 
values within the image has a bimodal distribution.  This assumption may not be valid 
when dealing with small, newly formed bone ossicles, (Figure 1) making this approach 
variable and potentially inaccurate.  In fact, when this approach was applied it resulted in  
threshold values which were at least 25% greater than the optimal thresholds (those with 
high R2 values when compared with reference data), leading to an underestimate in BVF 
if these autothresholds are used, reiterating its inadequacy for tissue engineered ossicles 
(Table 1). The second thresholding approach, and perhaps the most extensively validated 
for trabecular bone have required the use of local and/or adaptive thresholding 
techniques.26However, these algorithms can be difficult to implement and, as a result, one 
of the most common  thresholding techniques uses a simple global threshold.  For tissue 
engineered constructs, standardized global thresholding can be a problem because the 
thresholds may have been determined for mature bone of larger volume and, therefore, 
may underestimate the amount of newly formed bone.  This problem can be exacerbated 
if the heterogeneity within a specimen is large and if used between specimens18. These 
techniques are useful for bone tissue engineering,(Hedberg et al.) but the details of their 
application are seldom discussed.   
The underlying concept in this study is that the gelatin scaffold used to deliver 
transplanted cells will not directly affect bone measurements in a µCT image. This 
vehicle causes little to no interference because it has a radiodensity different than 
mineralized tissue and, furthermore, it degrades completely within 4 weeks eliminating 
the possibility of artifact from residual scaffold.  The lack of peaks in the histogram 
between the bone and water regions (Fig. 1) prove that degradation of the gelatin was 
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complete.  Therefore, a direct analysis could be made to compare the BVF calculated 
from the µCT data to the actual values determined from ashing the ossicles.   Ash content 
was normalized to the original tissue weight, to account for any discrepancies in size 
between the samples.  
The optimal threshold range for determining volume fraction of regenerated bone 
was in the 1000-1300 grayscale value range.  Confidence in this range of thresholds 
comes from 3 sources: (1) the range of 1000-1300 has a R2 > 0.87 and p < 0.05 (Fig. 
2,3,5), (2) the correlations and levels of significance quickly diverge as the threshold is 
set below 900 or above 1400, and (3) there is no significant difference in the BVF of 
ossicles measured between 1000 and 1300.  A slight increase in the threshold value with 
the highest R2 with respect to implantation time was observed when the 3D measures 
were compared (Fig. 2).  This time dependence suggests that mineral packs over time, 
and is therefore detected at a higher intensity at later times.  At earlier times, where the 
mineral is more dispersed, the amount of mineral present in a voxel might not be enough 
to be recognized at a higher threshold.  However, this time dependence was not present 
when 2D histological data was compared with analogous µCT sections (Fig. 3, Fig. 5).  
This may be due to the inherent 2D limitations of the histology, but this seems unlikely 
because overestimating (or underestimating) effects of a particular µCT section are 
corrected because they are being compared to their analogous closely aligned histological 
slide.  Another possible explanation for the difference in temporal sensitivity of the ash 
fraction and histological data is that the three-dimensional structure of the bone within 
the ossicle affects the thresholding process.  There may be more partial volume artifact in 
3D, and this may have an impact when making comparative measurements since the 
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ashing process will not be affected by partial volume problems.  Because of this, in future 
studies it may be prudent to select a single global threshold within the 1000-1300 range 
and apply it to constructs across the timepoints of interest.       
This study also compared the osteogenic potential of two cell sources in-vivo.  
Both BMSCs and BMP-7 transduced cells formed mineralized ossicles, but showed 
different patterns of tissue formation in-vivo.  The overall volumes of the regenerated 
ossicles were significantly different between the different cells and time (Fig. 7).  At 8 
weeks, the ossicles were not significantly bigger than their 4 week counterparts (Fig. 7), 
but had a significantly greater amount of bone within the implant (Fig. 6a, Fig. 7b). This 
suggests that bone apposition may occur by further mineralization of the bone that is 
present as well as new bone formation in areas that were previously unmineralized.  The 
12 week period shows that the ossicles became larger and, although it was not 
significantly different, tended to have a higher bone volume fraction. These effects may 
be contributing to the disparity in auto-threshold values (Table 1) observed in the three 
time periods.  The threshold value increases between 4 and 8 weeks, before decreasing.   
The overall size and mineral content of ossicles formed by BMP-7 transduced 
cells were significantly greater compared to the ossicles formed from BMSCs.  BMP-7 
not only stimulates osteoblastic differentiation of osteoprogenitors but may also 
differentiate the transduced non-osteogenic mesenchymal cells to osteoblast lineage cells 
2, 3, 39.  Cell-mediated recombinant protein delivery may be superior to direct growth 
factor implantation, because the continuous secretion of BMP-7 may act as a paracrine 
agent, diffusing into the surrounding host tissue and stimulating responsive host cells in a 
manner similar to that proposed for exogenous recombinant BMP-7.  Cell mediated BMP 
 39
delivery may also act as an autocrine agent to induce the osteoblastic differentiation of 
implanted cells.  Another possible mechanism is that one of the paracrine effects of 
secreted BMP-7 is to stimulate responsive cells to synthesize and secrete BMP and hence 
propagate the signal throughout the implant.    
The distribution results verify the qualitative observation that most of the mineral 
formation is on the periphery for the BMSC transplants (Fig. 8).  The development of a 
shell of bone on the periphery suggests that the cells on the outside differentiate more 
quickly, possibly because they are exposed to more signals and nutrients.  If it occurs 
before internal mineralization, this tissue formation at the periphery of a scaffold creates 
a border that increases the resistance to nutrients flowing in and byproducts flowing out, 
potentially leaving the inside cells trapped and undifferentiated 40.  Bone ossicles formed 
from BMP-7 transduced cells have more dispersed mineral, and are larger.  This decrease 
in mineral reduces the resistance of nutrients into the core of the construct, enhancing cell 
nutrition and decreasing the possibility of an undesirable micro-environment due to toxic 
byproducts.  BMP release from the transduced cells seems to enhance the rate of 
differentiation.  This is evident by the significantly higher mineral content in the 4 week 
group. This rapid differentiation leads to tissue formation throughout the construct.  
Based on our study, we hypothesize that co-seeding of BMP-7 transduced cells 
and BMSCs would have therapeutically advantageous results.  BMP-7 transduced cells 
would be used on the epiphysis area to enhance regional bone density, while BMSC 
would be placed to construct the shaft of long bones due to the matured bone marrow 
forming property, most mimicking the structural – functional characteristics of native 
bone. Such approach may be useful in future clinical trial to bone regeneration.  
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Other types of scaffolds that are non degradable, degrade at slower rates, or have 
densities closer to that of bone, such as Ca-P ceramics, may show their presence in CT 
images.  Such materials may also have intensities that overlap with or interfere with the 
detection of new bone, and the intensity will vary based on the amount and density of 
ceramic.  To overcome these potential complications in analyzing tissue engineered bone, 
scans of empty constructs should be taken at the selected threshold before implantation.  
Empty constructs should also be used as an in-vivo control for degradation.  Using these 
two controls, it is possible to more accurately determine the percent of voxels in a 
bone/scaffold composite that actually represent new bone.  The amount of bone can be 
determined from the difference between percent of voxels above the threshold in a 
bone/scaffold composite and the percent of voxels above the threshold in the starting 
scaffolds (or scaffolds implanted without cells if the scaffold is highly resorbable).  
Bounds on the contribution to BVF due to interference from a scaffold are therefore 
represented by the number of voxels in the scaffold at time zero (upper bound) and 
number of voxels in the remaining scaffold following implantation (lower bound).  Using 
this technique with ceramic scaffolds, we demonstrated that the optimal thresholds for 
engineered bone remain in the 1000-1300 range (Fig. 9).  If sufficient amounts of bone 
form within the scaffold, this should allow the amount of new bone to be calculated and 
validated histologically even though it may not be possible to directly visualize the new 
bone on a µCT image. In tandem with the consistency in threshold range between 
different cell types, this threshold range is therefore deemed to be generally valid for cell 
based tissue engineered bone. 
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One final note on the transformation of the threshold data in hounsfield units to 
other systems.  Several systems give a threshold value in terms of a physical mineral 
density (mg/cc).  Recent studies have shown a linear relationship between all the gray 






HUThrehsold Bone Mineral Density Threshold (mg/cc)  
 
This transformation was applied to the thresholds (HU) used in these experiments and are 
reported in table 2.   
 
2.5 CONCLUSIONS 
This study showed that the µCT is an accurate tool to analyze the bone content of 
ossicles. Using an autothresholding algorithm might lead to an underestimate of BVF 
because a fundamental underlying assumption of this algorithm is not satisfied.  Based on 
2 and 3 dimensional validations, a threshold range of 1000-1300 (24.2-31.5 % of Bone 
HU) is optimal for the early stages of bone formation.  This threshold should provide 














Table 1 Comparison between optimal thresholds determined from regressions 
against ash fraction and auto thresholds determined using histograms and threshold 





















Table 2 Linear transformations of threshold in Hounsfield units (HU) to 








Figure 2-1 Autothresholding mechanisms use a bimodal to find a threshold value 
by finding the midpoint of the intermodal zone.    
When mature bone (a) is analyzed using these autothresholding mechanisms, the typical 
separation the intensity peaks is even and easy to discriminate and a threshold can then be 
easily selected.  However, when the frequency of  mineral is low and tissue is still 
forming (b), such as in immature ossicles, the skewed unimodal distribution in the 
histogram violates an underlying assumption of the autothresholding algorithm making 
this approach difficult to employ. Furthermore, the lack of a bone peak makes it difficult 
to discriminate between new bone and marrow, fibrous tissue, fat and other soft tissue 




Figure 2-2 Correlation between volume fraction of regenerated bone determined 
by micro CT and ash fraction at different thresholds.   
The optimal regression is depicted by the line on each plot: (A) 4 weeks (B) 8 weeks, (C) 
12 weeks, (D) pooled times.  The correlation coefficients and % of bone HU for all 
thresholds are also shown (E).  The 1000-1300 range of thresholds yielded a correlation 
coefficient R2 > 0.87 for all time points and level of significance, p < 0.049. Significance 
(p<0.05) is denoted by *. 
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Figure 2-3  Correlation between area fraction of regenerated bone determined by 
micro CT and area fraction determined on same section by H&E staining.   
Regressions were performed for the (A) 4 week, (B) 8 week, (C) 12 week and (D) pooled 
time groups.  The correlation coefficients and % of bone HU for all thresholds are also 
shown (E).  The optimal threshold at each time is 1200, with R2 > 0.9.  Significance 














Figure 2-4 Comparison of von Kossa images that have been stitched together 
(left) and the analogous µCT planes (right) at (a) 4 weeks, (b) 8 weeks and (c) 12 
weeks for sections of ossicles regenerated from BMSCs.   
The slides demonstrated that there is increasing mineralization as a function of time, as 






Figure 2-5 Correlation between area fraction of regenerated bone determined by 
micro CT and area fraction of mineral determined by von Kossa staining on the 
same section.   
Regressions were performed for the (A) 4 week, (B) 8 week, (C) 12 week and (D) pooled 
time groups.  The optimal regression at each time is depicted on the plots.  Correlation 
coefficients and % of bone HU for all thresholds are also shown (E).  The optimal 
thresholds are 1000-1100 for all times.  The range of thresholds with the highest 
correlation coefficients and significance is consistent with the thresholds determined by 
regressions of the BVF with ash fraction and percent H&E stain. Significance (p<0.05)is 
denoted by *. 
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Figure 2-6 Bone regeneration as a function of cell type and time.   
(A) volume fraction of regenerated bone determined by micro CT - the volume fraction 
of bone regenerated with each cell type at each time was calculated at the respective 
optimal threshold.  There was a significant difference (denoted by *) in BVF between the 
4 week samples and the 8 and 12 week samples for both cell types.  There however was 
no significant difference between the cell types. (B) µCT renderings of the regenerated 
ossicles show increased mineralization as a function of time.  (c) H&E slides from both 





Figure 2-7 Overall volume and total mineral (ash) content of ossicles regenerated 
from transplanted BMSCs and BMP-7 transduced cells.   
The volume of the ossicles was significantly greater in the 12 week group compared to 
the 4 and 8 week groups in both cell types (a).   There was also a significant difference in 
overall volume between the two cell types (p<0.001 at all time points), with BMP-7 
constructs being approximately 2-fold larger.  The BMP-7 constructs were also larger 
than the original size of the gelatin sponge after 12 weeks. (b) the total mineral content 
was significantly greater in ossicles formed from BMP-7 transduced cells.  The total 
mineral content increased significantly after 4 weeks for both cell types. There was a 
significant difference between all times in the BMSC group, and between 4 weeks and 8 
weeks in the BMP-7 treated constructs. Pairs that are not significantly different are 
indicated by $.         
 






Figure 2-8 Quantification of mineral distribution on von Kossa stained slides for 
the 4 week samples.   
Percent mineral was calculated in 4 regions (0-25%, 25-50%, 50-75%, 75-100% of the 
area from the centroid to the periphery.  There is a significant difference (as denoted by 
*) in the percent of bone formed at the periphery and central parts of the gelatin foams 







Figure 2-9 Correlation between volume fraction of regenerated bone determined 
by µCT at different thresholds and mineral fraction determined by ashing when 
BMSCs are in a ceramic scaffold for 6 weeks.   
The optimal regression is depicted by the line on each plot.  The correlation coefficients 
and levels of significance for all thresholds are shown in the table.  The 1000-1300 range 
of thresholds yielded a correlation coefficient R2 > 0.95, supporting the general use of 
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Chapter 3 
Effects of Cell Seeding and Self-Mineralizing Template on Differentiation and 
Volume of Regenerated Bone 
3.1 Introduction 
Skeletal defects present a major clinical challenge with over 5.5 million fractures 
and 1 million bone grafting procedures done each year 1. Present surgical therapies for 
bone defects or bone loss in the skeleton include autografts  2-6, allografts 4, 5, and 
synthetic materials7. Each of these reconstructive and/or regenerative strategies, however, 
has limitations and lacks clinical predictability. Only a minimal amount of tissue can be 
harvested for autografts, the harvesting procedure may lead to donor site discomfort and 
morbidity, and it may be difficult to form this tissue into desired shapes.  Autografting, the 
current “gold standard” for bone regeneration, has failure rates as high as 30%. Allografts 
have the potential of transferring pathogens 3, 8(3,12). Freeze-drying, demineralization, and 
irradiation, which reduce immunogenic potential, can also reduce structural integrity, 
leading to graft fracture 3(3). Other complications with autografts and allografts include 
unreliable incorporation, resorption, and non-union of the graft/bone interface8-11.  
Induction of new bone by growth factors requires large amounts of recombinant 
material, which may not be realistic in cases of massive defects12. Additionally, successful 
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use of growth factors relies on the presence of a sufficient population of undifferentiated 
progenitor cells capable of responding to the inductive cues provided by the growth 
factor13. Synthetic materials are primarily designed to be permanently implanted. Long-
term complications include stress shielding, leading to loosening, and mechanical or 
chemical breakdown of the material itself7.  
A more biological alternative to the permanent implantation of synthetic materials 
is a cell transplantation approach where a 3-dimensional natural or synthetic construct 
provides a temporary substrate for cells to organize, grow, differentiate, and form a 
functional extracellular matrix and new tissue6, 14, 15.  Because bone regeneration is a 
complex process that requires autocrine, paracrine, and endocrine signals, positional cues, 
cell-matrix interactions, mechanical forces and cell-cell contacts to mediate the formation 
of a complex 3D architecture and function, an understanding of developmental processes 
may help identify strategies that can be used in tissue engineering.  Altering simple initial 
conditions may help maximize some of the necessary processes for tissue development, 
while solving some of the clinical limitations present in current strategies.  Two such 
initial conditions that can be easily manipulated are the substrate chemistry and the initial 
cell seeding.   
Of particular importance with the use of synthetic materials is that most problems 
manifest themselves at the biomaterial/tissue interface, in part because the tissue has the 
ability to functionally adapt, whereas the synthetic material does not. Manipulating the 
surface chemistry to be more biologically-interactive biomaterials could potentially 
improve the clinical treatment of bone defects.  A mineralized layer on the surface of a 
porous synthetic 3D scaffold can provide a physiologically favorable environment that 
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enhances cell adhesion and osteoconductivity 16, 17.  Asides from substrate effects, 
calcium/phosphate apatites may have a solution mediated effect when the mineral layer 
starts dissolving, releasing ions that can serve as both extracellular and intracellular 
messengers.  For example, the release of calcium ions (Ca2+) into the solution can enhance 
osteogenic differentiation, cell growth, and cell-to-cell signaling17-21.  Furthermore, once 
up taken by cells, Ca2+ ions become an important intracellular messenger in all bone 
forming cells, enabling remodeling and regeneration22, 23.   
Substrates, biologically active or synthetic, are typically seeded with cells via the 
commonly employed static seeding technique.  This technique relies on gravity as a 
gradient to percolate cells into a porous scaffold, allowing cells to passively attach to the 
surface of the 3D construct.  Although simple in nature, this approach has limitations due 
to initial cell adhesion, as well as diminished transport of nutrients, signals, and 
messengers 24-26.  As such, tissue regenerated from cells seeded statically, typically 
exhibits only partial regeneration. The regenerated tissue is also characterized by 
regeneration of tissue in the periphery of the 3D ossicle, while only small amounts of 
bone are generated in the core.   
Alternatively, modifying the initial seeding conditions, via novel seeding 
techniques, may provide a means to enhance nutrient transport, cell adhesion, and cell-
cell communication in 3D scaffold.  Such initial seeding conditions may alter the 
eventual fate of the resulting tissue, indicating the potential impact seeding may have on 
tissue engineered equivalents.  Two novel techniques, seeding by filtration and 
micromass seeding, may enable higher cell-adhesion rates, cell density, and cell-to-cell 
communication. Seeding by filtration occurs by circulating a dense cell suspension 
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through the scaffolds, with the aid of a small pressure gradient applied by a peristaltic 
pump. The homogeneous cell suspension that filters through the scaffold is cycled 
through and may produce higher cell density and even cellular distribution.   Micromass 
studies have been performed in-vitro, in a 2D monolayer 27.   This seeding strategy is 
achieved by placing a super-dense cluster of cells at a particular location in a 3D scaffold; 
leaving less crowded areas were nutrients can flow through.  Micromasses could provide 
the benefits of higher density, cell-cell communication, and nutrient and byproduct flux 
thought to be vital to the proper development of tissue. 
Our study aims to investigate a critical question in tissue engineering; namely, can 
altering simple exogenous initial conditions, specifically surface chemistry and seeding 
conditions, alter the fate tissue engineered bone equivalents?  To examine this question, 
we compare cell adhesion, cell-to-cell communication, osteogenic differentiation and 
osteogenic patterns of regenerated bone in-vivo, in synthetic and biomimetic mineralized 
templates, as well as in scaffolds seeded with cells via static, filtration, and micromass 
seeding.  The impact of this study may reach the clinical setting, by providing tissue new 
simple, in-expensive, and replicable strategies that regenerate larger and more evenly 
distributed amounts of bone.   
 
3.2 Materials and Methods 
3.2.1 Bone marrow stromal cell (BMSCs) isolation and culture 
Five-week old C57BL/6 mice were used to isolate bone marrow cells from the 
femoral, tibial and humeral cavities (six bones per animal) as previously described28. 
Briefly, the bone marrow was mixed with minimum essential medium (α-MEM; Gibco 
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Laboratories, Grand Island, NY) containing 10% fetal bovine serum (FBS) (Gibco) and 
antibiotics (100 µg/ml penicillin G and 100 IU/ml streptomycin at 37°C in 5% CO2/95% 
air). Cells were pelleted by centrifugation at 1000 rpm for 5 min at 4°C and resuspended 
in 10 ml α-MEM. Cells were plated at a density of 30,000 nucleated cells/cm2, and 
cultured under the same conditions. The culture medium was replaced three times per 
week and at near confluence (90%) the adherent cells were washed with phosphate- 
buffered saline solution and enzymatically released by means of a 0.25% trypsin-EDTA 
(Sigma, St. Louis, MO). Cells were re-plated at a density of 30,000 cells/cm2 and 
passaged 7-10 days after, when confluence was achieved.  Cells were passaged twice 
before they were used in the subsequent experiments. 
3.2.2 Scaffold Preparation 
Porous, 3D organic templates (85:15 poly(lactide-co-glycolide), diameter = 4mm 
x height = 1mm, 90% porosity, pore size 250-425µm) were prepared by a solvent 
particulate leaching process explained elsewhere 29-31. 
3.2.3 Mineralization of Scaffolds  
Scaffolds were each incubated in a 50-mL solution of modified simulated body 
fluid (SBF) for 7 days for mineral film formation 32.The SBF solution was changed every 
24 h to ensure sufficient ion concentrations for mineral growth. The SBF was prepared by 
dissolving the following reagents in deionized water: 141 mM NaCl, 4.0 mM KCl, 0.5 
mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0mM CaCl2, and 2.0 mM KH2PO4. 
SBF was buffered to maintain a pH 6.8 with Tris-HCl at 37°C for the duration of the 
incubation period. 
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3.2.4 Pre-Wetting Scaffolds 
Scaffolds were pre-wet with 70% ethanol by pressing wet pads around the surface 
area for 5 minutes.  Afterwards, scaffolds were submerged in 50ml falcon tubes filled 
with α-MEM and agitated 30 minutes to remove the excess ethanol.  The scaffolds were 
removed from the tube and placed into a new one with fresh α-MEM. The process was 
done 5-6 times until the pH of the α-MEM in the tube matched that of the sterile α-MEM 
(pH=7.1).  The scaffolds were then left to soak in the media overnight before seeding. 
3.2.5 Cell Seeding 
The experimental design assessed three methods of seeding (static, dynamic, and 
filtration) at three time points (1hr, 6hrs, and 24hrs), using both mineralized and non-
mineralized PLGA scaffolds. 6 scaffolds were used for each procedure, for a given time 
point and material.  Static seeding was performed in 24-well plates by pipetting a cell 
suspension into the scaffold.  Each well contained 1 scaffold.  A cell suspension of 1ml  
(α-MEM; containing 10% fetal bovine serum (FBS) and antibiotics (100 µg/ml penicillin 
G and 100 IU/ml streptomycin at 37°C in 5% CO2/95% air), and cell density of 0.8EE6 
cells/ml) was used in static, dynamic, and filtration seeding experiments.  The scaffolds 
were placed into the incubator (at 37°C in 5% CO2/95% for all seeding methods) 
immediately after.  Dynamic seeding was performed by trapping two scaffolds in a 15 
ml falcon tube, between meshes, with a stir bar outside the meshes in the bottom of the 
tube. Because the number of cells was desired to be kept constant, about 5mL of media 
were added to the cell suspension so that both scaffold and stir bar would be completely 
submerged.  The cell suspension was poured into the tubes, and these were placed in a 
stir plate inside an incubator. The stir intensity was set at 150rpm. In filtration seeding 4 
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scaffolds were placed in 4 glass cylinders of the same radius. The cell suspension was 
circulated through the scaffolds with a small gradient applied by a peristaltic pump 
(1.37ml/min) through small non-stick tubes (silicon tubes, Small Parts Inc, ID=3.5mm). 
A homogeneous cell suspension is kept by adding a stir bar to the suspension reservoir.  
Scaffolds (D=4mm, t=1mm) were placed in a cylindrical scaffold chamber (ID=4mm, 
20mm).  The chamber is made of non-stick glass so that the cells won’t attach to its 
surface and only attach to the scaffolds. In order to generate a laminar profile and keep 
the pH at 7.4, the length of the tubes was set at 0.3m (Appendix A1, A5).  The complete 
system was placed in a CO2 incubator, to promote gas exchange through the tubes.  Cells 
that are not seeded in the first filtrate are passed through several times until maximum 
retention is reached. The mean residence time of cells was approximately 30 mins.  
Therefore, every 30 mins, the direction of the flux was changed to avoid directional bias 
on the scaffolds.  In Micromass seeding, the cell suspension was more concentrated and 
pipetted into the middle of the scaffold (4.0EE6 cells/ml). 
3.2.6 Cell Counting and Histology 
After seeding, the scaffolds were washed five times with α-MEM to retrieve all the free 
(unattached) cells.  The five wash benchmark was chosen after test studies confirmed that 
there was a negligible amount of free cells left in the scaffold after the 5th wash.  The 
washed fraction was pooled and saved to count the free cells present in the media.  The 
apparatus and containers were also washed to determine the number of cells that did not 
adhere.  Free cell count was obtained using a hemacytometer.  The % of cells that 
adhered to the scaffold was determined by subtracting the number of washed cells from 
the number of cells originally seeded.  To verify this counting strategy, 4 scaffolds from 
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each seeding condition were treated with trypsin-EDTA, to remove the attached cells.  
Trypsinization was performed for two minutes, followed by flushing of cells with α-
MEM.  This process was repeated 3 times per scaffold, and the 3 resulting cell 
suspensions were pooled to obtain the number of attached cells.  Cell counts from 
micromass seeded scaffolds obtained via these two methods are not reported because the 
count was inconsistent and the treatment destroyed some cells.  A 3-way ANOVA on 
time, template, and seeding strategy was performed to determine significant differences 
in percentage of seeded cells (p<0.005).   
As an alternative three scaffolds for each seeding strategy and time were analyzed 
histologically to quantify cell retention and qualitatively observe the distribution of 
attached cells.  Scaffolds were fixed in 10% buffered formalin and ethanol. 5 µm sections 
were made and placed on 10 slides with 3 sections per slide.   Sections were standardized 
for all scaffolds in 200µm increments from the surface. The number of cells per section 
was quantified and the mean number of attached cells per section is reported.  
Differences in cell counts were assessed using a 1-way ANOVA on 6 hour sections and 
differences were assessed at p>0.005.   
3.2.7 Dye transfer studies  
Fluorescent dye transfer studies were performed to assess gap-junctional 
intercellular communication (GJIC) between BMSCs seeded in mineralized and non-
mineralized scaffolds by static, filtered and micromass seeding strategies.   The cell 
scaffold constructs (4x1mm) were seeded as previously described for 24 hours and placed 
in 24 well plates. Cells in these circumstances served as recipient cells.  Calcein-AM 
(10uM) and Vybrant-DiI were used to label donor cells grown to confluence in a 12-well 
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plate. As a negative control, 50uM of the gap junction uncoupler alpha-glyccirrhetinic 
acid (AGA) was used (n=5). Donor cells were added to potential recipient cells at 1:8 
ratio.  Cells were harvested by trypsinisation for quantitative assessment of GJIC by flow 
cytometry after 5 hours. .  The transfer regions for recipient cells (> 2x101 Fl-1 and < 
5x103 Fl-1) and  non- labeled, non-recipient cells (< 2x101 Fl-1) were defined as the 
transfer regions based on the initial fluorescence range quantified for  non recipient cells, 
and cells containing both dyes.  Florescence above 5x103 Fl-1 was indicative of cells 
containing both membrane tracker and calcenin-AM.  The transfer fraction of cells was 
determined normalizing the value of the transfer region to the total number of recipient 
cell counts. This experiment was performed with n=6 groups.  Statistical differences in 
percent of dye recipient cells were measured using a 2-way ANOVA on template and 
seeding strategy (p<0.05). 
3.2.8 RTPCR Analysis of differentiation markers 
BMSCs were seeded in Mineralized and non-mineralized scaffolds by static, 
filtration and micromass strategies.  The seeded constructs were placed in 24 well plates 
supplemented with osteogenic media (α-MEM media, 10%  Fetal Bovine Serum, 1% 
Pen/Strep, 1% 100x β-Glycerophosphate, 1% L-ascorbic acid-phosphate, ~ 0.05%,   ~ 
0.05%  Dexamethasone).  An additional group in which 1.5mM of Ca2+ was added to 
osteogenic media was tested to assess the effects of soluble calcium.  Media was 
replenished every 24 hours, to ensure optimal nutrient contents in the surface of the 
scaffolds.  At 2, 8, and 16 days for analysis real-time PCR was used to detect the 
expression of two bone differentiation markers (Alkaline Phosphatase (ALP) and 
Osteocalcin (OCN)). Primers and TaqMan probes were purchased (ABI).  The primer 
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sequences utilized were as follows:  OCN, 5'-CCAGCGACTCTGAGTCTGACAA-3', 
and  
5'-CCGGAGTCTATTCACCACCTTACT-3';  ALP; 5'-GCCCTCTCCAAGACATATA-
3' and  5'-CCATGATCACGTCGATATCC-3' 
Cells seeded scaffolds or in 12 well plates were trypzinized after 2, 8, and 16 days, 
to remove cells and the total RNA was extracted (Trizol; invitrogen Corp). The RNA was 
purifed (RNeasy, Quigen) and treated with DNAse I.  Cycling conditions were as 
follows:  50C for 2 minutes and 95C for ten minutes, followed by 50 cycles of 95C for 15 
seconds and 60C for 1 minute.  No-template control analyses were run for each primer set 
and 18s rRNA (ABI) endogenous control was run for each sample.  Analysis was 
performed by first setting an appropriate standard threshold level in the linear part of the 
reaction for each primer.  The crossing value of this threshold was determined (Ct) for 
each sample.  Using the manufacturer’s protocols (ABI Prism 7700 Sequence Detection 
System, User Bulletin #2), mRNA expression levels for each sample/primer were 
normalized to endogenous  rRNA 18S levels and the results were reported as a fold 
change relative to the OCN expression of BMSCs (filtration seeding, day 2). Filtration 
seeding was chosen as the normalizing seeding condition because the variation between 
samples was relatively low compared to static and micromass seeding techniques.  All 
reactions were performed in quintuplets. Three 1-way ANOVAs were used to determine 
significant differences as a function of seeding condition, scaffold, and time.   
Cell seeded constructs were trypzinized after 2, 8, and 16 days, to remove cells 
and the total RNA was extracted (Trizol; Invitrogen Corp). The RNA was purifed 
(RNeasy, Quigen) and treated with DNAse I.  Cycling conditions were as follows:  48C 
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for 10 minutes and 95C for ten minutes, followed by 4 cycles of 95C for 15 seconds and 
60C for 1 minute.  No-template control analyses were run for each primer set and 18s 
rRNA endogenous control was run for each sample.  The 2∆∆CT relative quantization 
method was utilized to evaluate gene expression.  All reactions were performed in 
quintuplet and n=4. The results were normalized to the endogenous 18s expression (ABI).  
A 3-way ANOVA was used to determine significant differences as a function of seeding 
condition, scaffold, and time.   
3.2.9 Transplantation of cell-scaffold constructs 
Cells were seeded by static, filtration and micromass seeding as previously 
described. All cell-scaffold constructs were placed in an incubator for 1 hour (at 37°C in 
5% CO2/95%) until surgery began, to ensure sterility until the moment of implantation.  
24 Mineralized and 24 PLGA constructs were transplanted subcutaneously into nude 
mice (nu/nu). Each of the construct groups contained 6 filtered, 6 micromasses, 6 static, 6 
empty scaffolds.  Briefly, nude mice (nu/nu) were anaesthetized by an intraperitoeal 
injection of 1 mg/10 g ketamine and 0.1mg/10 g xylazine. An incision was made on the 
back of each mouse and the implants were inserted within the subcutaneous cavities. The 
cell-scaffold specimens were assigned randomly to each pocket.  The wounds were 
closed with surgical clips aseptically. The mice were euthanized after 6 weeks and the 
regenerated bone ossicles were harvested. 
3.2.10 Micro-CT 3D image acquisition and analysis 
Ossicles, clear of soft tissue, were scanned on a high resolution cone beam micro-
CT system (Enhanced Vision Systems (now GE Healthcare Preclinical Imaging), London, 
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Ontario, Canada) while immersed in distilled H2O. The x-ray source voltage and current 
were 80 kVp and 80µA, respectively. To reduce the potential for beam hardening artifact, 
the x-rays were passed through a 0.2mm Al filter immediately upon exiting the source 
and the specimens were immersed in dH2O during the scanning process. Projection 
images were acquired over 198 degrees using 2x2 binning and an exposure time of 1100 
ms, and four frames were averaged for each projection to improve the signal to noise 
ratio. The projection data was then corrected and reconstructed using the Feldkamp cone-
beam algorithm to create three-dimensional images with an isotropic voxel size of 18µm.  
The scanner was calibrated once daily using a phantom that contained air, water and 
hydroxyapatite. 
Bone volume fractions were determined by using a MatLab program designed to 
integrate all grayscale voxels above a particular threshold.  To determine the overall 
volume of the ossicles, the program determined the perimeter of each 2D µCT slice by 
tracing the outer edge. The program then integrated all the perimeters to determine the 
3D surface area, and the number of voxels inside the surface defined the total volume.  
High density voxels outside of the 3D surface and unattached to the ossicle were 
discarded, while voxels inside were evaluated at the specified thresholds to determine the 
BVF, which was calculated as the number of voxels above the threshold relative to the 
total number of voxels.  Using this method, a threshold of 1100 was used to re-construct a 
rendered image of the ossicles and determine their distribution 33.   
3.2.11 Histological analyses 
The ossicles were rinsed in water and then decalcified in 10% formic acid for 5 
days. After decalcification, the tissues were embedded in paraffin. 5 µm sections were 
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made and placed on 10 slides with 3 sections per slide. The tissue was deparaffinized 
hydrated, and the first, fifth, and tenth slides were stained with H & E, and von Kossa. 
Image Pro Plus 4.0 was used to take pictures of the histological sections. 
3.2.12 Analysis of bone ingrowth 
A program was developed to determine the distribution of regenerated bone as a 
function of the distance from the geometric center of each ossicle.  Using von Kossa 
stained sections of bone ossicles regenerated in PLGA scaffolds, the centroid was 
calculated using a MatLab script 34and used as a frame of reference to divide the ossicles 
into 4 regions.  Defining the centroid as the 0th percentile and the edge as the 100th 
percentile, boundaries were calculated by lines that radially pointed into the center from 
the edges.   Using this criterion, the program determined the percent of bone present in 
regions 0-25%, 25-50%, 50-75% and 75-100% of the area away from the centroid.  A 2-
way ANOVA was performed to differentiate between (1) sections in filtered and 
micromass generated ossicles and (2) topographical regions within each ossicle; 
significance was measured at p<0.05. 
 
3.3 Results 
3.3.1 Filtration seeding achieves a higher number of attached cells  
Filtration seeding led to significantly higher percentage of cells adhered than 
dynamic or static seeding (figure 1).  Scaffolds filtered with cells had high cell retention 
after 1 hour (82.4+/-4.1%) and approached carrying capacity by the 6th hour 
(92.32+/6.12).  Both dynamic and static seeding increased as a function of time but had 
 72
significantly less cell adhesion than filtration at all times (p<0.001, for all times).  
Dynamic also achieved significantly higher number of attached cells than static seeding 
(p(1hr) =0.003, p(6hrs)<0.001, p(24hrs) =0.021).  The effect of template was only 
significant in the static seeded scaffolds, where the mineralized layer enhanced adhesion 
(p(1hr)=0.031, p(6hr) =0.028).  There was no significant difference in cell adhesion 
between mineralized and non-mineralized scaffolds seeded by filtration and dynamic 
seeding.  Histology verifies the adhesion results.  The slides qualitatively show that 
filtration (figure 2C) has an increase in cell number and spatial distribution when 
compared to static (figure 2A), dynamic (figure 2B), and micromass seeding (figure 2D).  
Micromass seeding exhibited significantly higher cell counts than static seeding  after 6 
hours in both mineralized and non-mineralized templates (p>0.001). Histology showed 
that micromass seeded scaffolds exhibited highly dense centralized localization of cells.  
Quantitatively (figure 2E),  6 fold increase in the number of cells attached in filtration 
over static seeding, and validated dynamic seeding and micro mass seeding as suitable 
seeding techniques that show significantly greater cell adhesion than static seeding 
(p<0.001, for both over static seeding).  The standard deviation in cell cluster number is 
significantly less in filtered seeding than the other methods (138.7+/-10.2 cells counts).  
Micro mass seeding had the highest deviation (68.0+/-23.4 cells counts).  
3.3.2 Micromass seeded cultures enhance gap junction dependent cell-cell 
communication 
A significant increase in calcenin-AM transfer between donor and recipient cells in the 
micromass seeded cells after 5 hours (figure 3) over filtered and static seeded cells 
(p=0.034, p<0.001, respectively).   The presence of a mineralized scaffold had no effect 
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in calcenin transfer.  However, in mineralized scaffolds, transfer in filtered seeded cells 
and micromass seeded cells is only moderately significant (p=0.92).  Furthermore, cells 
containing the gap junction inhibitor AGA, showed little transfer compared to both 
experimental groups without AGA (p<0.001) in both mineralized and PLGA scaffolds, 
indicating GJIC dependent transfer.   
3.3.3 Seeding and template conditions alter bone marker expression 
Expression of bone differentiation markers ALP and OCN was significantly 
altered when different scaffolds and seeding techniques were implemented (figure 6).  At 
day 2, ALP expression was significantly higher in micromass seeded than both filtration 
and static seeded scaffolds (p<0.001 for both), which exhibited no difference in the 
differentiation marker (fig 6a). At day 8, micromass seeded scaffolds still exhibited 
significantly higher expression when compared to filtration and static seeded scaffolds 
(p<0.001 for both), however, filtration also significantly expressed more ALP than static 
(p<0.001).  At day 16, there was no significant difference in ALP expression between 
seeding methods.   
`Expression of osteocalcin (fig 6 b) was different starting at day 8, where 
micromass seeding exhibited significantly higher expression (p<0.001 for both) 
compared to filtration and static seeded scaffods.  At day 16, OCN expression in 
micromass seeded scaffolds was significantly greater than filtration and static seeded 
scaffolds (p=0.0211).  Cells seeded through filtration expressed significantly higher OCN 
than statically seeded cells (p<0.001). 
Template mineralization and the presence of soluble calcium increased ALP and 
OCN expression over cells seeded in PLGA scaffolds (figs 4C-F).  Cells seeded in 
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mineralized templates by all seeding conditions expressed significantly larger amounts of 
ALP than cells seeded in PLGA scaffolds (fig 4 C,D; p=0.021).   Increasing the 
concentration of soluble calcium to cells seeded in PLGA exhibited a significant increase 
when compared to cells seeded in PLGA.  Filtered and static seeded scaffolds exhibited 
significant increases in expression (p=0.032, p=0.042), while only moderately significant 
in micromass seeded cells (p=0.099).   
Mineralized scaffolds enhance bone formation: H&E slides showed normal bone 
containing marrow that included fat, entrapped cells and hematopoietic cells for all 
groups seeded in mineralized scaffolds (figure 5 A-E). Static seeded scaffolds exhibit 
small bone formation with, but no marrow.  In general, when a mineralized template is 
use, cells regenerate more bone (Figures 5A-G). Bone formation is observed in the 
periphery of ossicles produced by filtered seeded cells, with increasing shell thickness in 
the mineralized scaffolds (figure 5 B,E). Bone generated by micromass seeded scaffolds 
showed bone growth in the core of the ossicles (Figure 5A,D) and entrapped cells 
morphology indicative of bone tissue.  Statically seeded produced marginal bone 
formation in PLGA scaffolds and was clearly aided by the presence of a mineral layer in 
the scaffold (figure 5 C,F,E).  
Micromass and filtration seeding led to a higher BVF than static seeding (figure 
5G). There was no significant difference in BVF between the filtered (27.3 +/-2.5) and 
micromass (31.2+/-6.2%).  However the percentage of variability was higher on the 
micromass seeded construct than the filtration.  Filtered, micromass and statically seeded 
mineralized scaffolds showed significantly higher BVF (p values = 0.013, 0.037, 0.009, 
respectively) than the PLGA seeded counterparts.   
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3.3.4 Different seeding techniques led to distinct patterns of osteogenesis  
Distribution analysis performed on Von Kossa sections verified the qualitative 
observation in the H&E sections, showing a quantitative difference in the distribution of 
mineral location in micromass and filtered ossicles (figure 9a).  The filtered ossicles 
showed most of the mineral in the periphery while the micromass ones had a more even 
distribution (figure 6B).  The ossicles generated by filtration seeding showed significantly 
higher BVF in the periphery (75-100%) than in the core (0-25%; p <0.001).   The 
micromass seeded ossicles have significantly more mineral in the core (p=0.0213), and 
significantly less (p=0.0311) in the periphery than the filtered ones (figure 9b).   There 
was no significant difference in BVF between topographical regions in the ossicles 
generated by micromass seeding. 
 
3.4 Discussion 
Our data suggests that altering the initial cell seeding conditions and/or using a 
biomimetic mineral template, can have a profound impact on both the amount and spatial 
distribution of regenerated tissue.  Explicitly, we showed that the initial conditions of 
mineralizing a polymer scaffold (PLGA) and seeding cells through the novel filtration 
and micromass techniques, as opposed to the conventionally used static seeding 26, 35, 
enhanced osteogenic differentiation in-vitro and regeneration of bone in-vivo in the 
longer term. Furthermore, we showed that the filtration and micromass seeding enabled 
higher gap junction intercellular communication between cells in 3D, an important 
component for tissue development and homeostasis36-39.  Coupled together, we speculate 
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that our results provide simple alternatives that can have a profound impact on the 
regeneration of 3D tissue equivalents.   
Mineralized templates had a significant effect both in cell differentiation in a 3D 
scaffold (figure 4), and in the amount of regenerated bone in-vivo (figure 5).  The 
examination of differentiation under 3D conditions was important; recently, our group 
and others have demonstrated differences in cell differentiation between a 2D monolayer 
and 3D cultures (Chapter 5,).  The differentiation data contained a group that only 
contained soluble calcium.  In these cases, there was moderate or significant increase in 
differentiation, relative to cells seeded in PLGA scaffolds.  However, cells in mineralized 
templates, in general, had significantly higher differentiation marker expression than the 
soluble calcium group. This suggests that both soluble and insoluble calcium in these 
biomimetic scaffolds play an important role in differentiation.  When cells were seeded in 
mineralized templates, the ossicles regenerated had a significantly higher BVF, relative to 
ossicles regenerated by cells seeded in PLGA.  Perhaps the most significant effect is 
observed in the static seeded scaffolds, whereby the presence of a mineral layer, enables 
bone formation to occur, with entrapped cells in a peripheral shell formation, and marrow 
cavities forming, compared to partial sections of hard tissue with some entrapped cells 
observed in the polymer group. These results suggest that a mineralized layer provides a 
favorable physiological environment for cells to thrive, differentiate and regenerate tissue. 
In our studies the effects of adhesion due to a biomimetic surface was also 
investigated.  Other studies have shown that such a calcium/phosphate coating can 
enhance cell adhesion 40-42.  However, our results show that, only when statically seeded 
did cells adhere at higher rates in mineralized scaffolds over PLGA (figure 2).  Scaffolds 
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seeded through dynamic and filtration seeding exhibited similar rates of adhesion.  The 
results for the statically seeded scaffolds are therefore consistent with results of others, 
yet, coupled with our dynamic and filtration data, suggest that the effect of surface 
mineralization is less important than cell seeding strategy. Also, mineralized scaffolds did 
not have an effect on GJIC (figure 3).  This may be due the short term nature of the 
experiments, as other groups have shown that external influences by calcium can increase 
the GJIC in cells 18.   
Altering seeding conditions had a significant impact in the number of adhered 
cells in culture, cell density, cell-to-cell communication, differentiation and patterns of 
osteogenesis.  Filtration, dynamic, and micromass seeding showed significant increases 
in cell adhesion over static seeding.  This result is promising, by enabling higher cell 
retention in constructs that may have other biologically favorable benefits, but are hard to 
seed due to their rigid nature.   Filtration provides a mechanism for uniform and complete 
capacity seeding of a 3D structure (figure 1, 2), while micromass enables the targeted 
location of a dense cluster of cells.  Cells seeded by filtration and micromass were 
analyzed for their capacity to engage in cell-to-cell communication, and compared to 
cells seeded statically.  We chose to investigate this factor as intracellular communication 
through gap junctions is essential for proper development of tissues and homeostasis, 
specifically in bone 43, 44.  The data clearly shows significant increases in GJIC, in both 
micromass and filtration seeded cells when compared to static seeded cells.  This 
suggests that the higher cell density increases the formation of gap junctions between 
cells, enabling a higher grade of communication.  Whether it is the increased proximity of 
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cells or the increased stress experienced by the cells the predominant factor enhancing 
GJIC remains to be elucidated.  
Differentiation of cells in a 3D constructs provide insights into the actual 
processes occurring within these scaffolds.  The data showed enhanced differentiation 
due to the initial alteration in cell seeding.  Specifically, cells seeded in micromasses 
exhibited early signs of differentiation, expressing high levels of ALP in the 2nd day after 
culture.  Coupled with the early expression of the late differentiation marker, osteocalcin 
(fig 4B), the results imply that micromass seeded cells prompts differentiation onset 
faster than the other methods.  It is also evident that differentiation in filtered seeded cells 
was greater than in static seeded scaffolds (Fig 4A, B), although different than cells 
seeded in micromasses.   One explanation may be that cells in micromasses experience 
more nutrient and byproduct transport 27 than the supersaturated cells in filtered scaffolds .  
Although both have the benefits of high density, transport and cell migration may play a 
role in differentiation.  
  Bone regeneration was also altered significantly as a function of seeding.  
Ossicles regenerated from filtered and micromass seeded cells, produced larger volumes 
of bone compared to static seeded cells (fig 5).  This result was particularly important 
when cells were seeded in PLGA scaffolds, as bone regenerated from statically seeded 
cells was characterized by sporadic bone formation, without marrow cavity or entrapped 
cells (fig 5F). Not only did ossicles form from filtered and micromass seeded scaffolds 
with higher volumes of bone, but the distribution of tissue was significantly different in 
these two strategies.  When seeded by filtration, cells produced a peripheral shell of bone, 
with diminished bone formation in the core of the ossicle.  This may be due to cells 
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thriving and differentiating in the periphery of the construct, while transport is 
increasingly impaired, thereby compromising tissue regeneration in the core of the 
scaffold.   This contrasts the spatially distributed formation of bone that characterizes 
ossicles regenerated by micromass seeded cells.  This increased presence of bone 
formation in micromass seeded ossicles may be due to both cell migration, nutrient 
transport and, a gradient of differentiation.  Because cells are seeded in the core of the 
scaffold at high densities, and differentiation starts promptly, it enables formation of bone 
in the center.  Cells may also migrate outward or inward from the body, and start 
differentiating at a later time, causing a differentiation gradient.  The end result is a more 
spatially distributed and uniform tissue equivalent. Future studies may look at the 
potential effects of migration in micromass seeded scaffolds.  The distribution studies in 
tandem with the overall analysis of the ossicles, strengthens the claim that altering the 
initial seeding conditions of cells can modify the amount and distribution of bone, and 
with future studies, such regeneration patterns may be achieved by design. 
In conclusion, we showed that both a biomimetic mineral template and the 
manipulation of initial seeding conditions can have profound effects on the resulting 
differentiation and in-vivo regeneration of bone.  Biomimetic templates provided a 
physiologically favorable environment for BMSCs for tissue formation, while altering the 
seeding conditions in these rigid 3D scaffolds enabled higher cell adhesion, cell-to-cell 
communication, and larger volumes of bone with distinct patterns of regeneration.  
Altogether, our study addresses and provides a mechanism to solving the critical question 
of full tissue equivalent regeneration by showing that, with simple manipulations of the 
initial cell and template conditions, one can significantly enhance the regeneration and 
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spatial distribution of tissue in-vivo; which has a major impact on bone regeneration and 





















Figure 3-1 Percent of cells adhering to PLGA (A) and mineralized (B) scaffolds 
at different time points following seeding via different techniques.   
Using a filtration approach produces significantly more adhesion and cell retention than 
both dynamic and static seeding (p<0.001).  Filtration reaches a plateau after 6 hours.  
Both static and dynamic techniques increase the number of adhered cells as a function of 
time. There were no differences in adhesion between mineralized and PLGA scaffolds, 
with the exception of static seeding at 1 and 24 hours.  Bars indicate pairs that were not 
significantly different.  Boxes denote groups that showed significant difference in 




Figure 3-2 Cell count and distribution varies in seeded scaffolds, 6 hours after 
seeding.   
Histological slides demonstrate the even distribution and high cell adhesion produced in 
scaffolds that were seeded through filtration (A).  Static seeding (B) is characterized by a 
lower yield of cells that are un-evenly allocated throughout the sections.  Dynamic 
seeding showed sections with densely packed cells but also a large variation in cell 
location (C).  Micromass seeding technique was validated showing a densely packed 
group of cells in the core of the scaffold.  Quantification of the mean cell count (E)in 
histological demonstrates that filtration, dynamic, and micromass seeding techniques 
enable more cell adhesion (p<0.001). There was no significant difference between 







Figure 3-3 Seeding alters gap junction intercellular communication.   
Cells seeded in PLGA scaffolds by micromass transferred calcenin at a higher fraction 
(63.2+/-10.6%) than both filtered (46.2+/-5.4%) and static seeded cells (23.6+/-6.9%). 
Although there was no significant differences in transfer between cells in mineralized and 
PLGA scaffolds (for all seeding strategies),  micromass and filtered seeded cells exhibit 
no significant difference in transfer when seeded in a mineralized scaffold (p=9.2).  Cells 
treated with AGA show significantly less transfer than those that were not, as well as 
showing no difference between seeding conditions exposed to the gap junction uncoupler.  
This indicates a gap junction dependent transfer of calcenin.  Horizontal bars indicate 







Figure 3-4 Expression of differentiation markers is increased with alternative 
seeding techniques and a mineralized template.   
Alkaline phosphatase (A) and Osteocalcin (B) expression increased significantly in cells 
seeded by micromass over filtration (ALP: p(day2)<0.001, p(day 8)<0.001;  OCN: p(day 
8)<0.001,  p(day 16) =0.0211) and static seeding ALP: p(day2, day 8)<0.001; OCN:  
p(day 8, day 16)<0.001).  Cells seeded in a mineralized template and calcium rich 
environment also expressed higher levels of ALP (C) and OCN (D) over cells seeded in 
PLGA.  Cells seeded in mineralized templates expressed significantly more ALP and 
OCN in all seeding techniques over cells seeded in PLGA-only (ALP: p(day2)0.031, 
p(day 8)<0.001 p(day 16) <0.001;  p(day2)<0.001 OCN: p(day 8)=0.033,  p(day 16) < 
0.001).  Although cells seeded with increased extracellular calcium did not exhibit a 
significant difference in ALP relative to those seeded in PLGA,  it did exhibit significant 




Figure 3-5 Volume fractions and patterns of osteogenesis vary as a function of 
scaffold surface and  seeding techniques.   
Macromass seeded scaffolds produce smaller ossicles, with a more abundant 
mineralization in the core of the scaffold (A, D). Filtered scaffolds (B, E) show a larger 
shell of bone formation with little or no mineralization in the core of the scaffold in both 
CT renderings and H&E histological sections.  Static seeded scaffolds produce scant 
mineralization and bone formation (C, F).  Mineralization enhances mineral coverage and 
BVF in all groups.  These significant differences as a function of  surface material and 
initial seeding were quantified (G).  Both the micromass and filtration seeding yielded 
significantly larger BVF than static seeding (p<0.001). Although there was no significant 
difference between the filtration and macromass seeding, the variability is 2-fold greater 
in the macromass implants. Mineralized scaffolds showed a significantly higher BVF 
with all seeding techniques than did their PLGA counterpart (p(micromass)0.037, 





Figure 3-6 Topographic analysis of mineral distribution within bone ossicles.  
In order to quantify the observed differences in mineral distribution through out the 
ossicles, cross sectional slides where analyzed with a program designed to calculate the 
topographical distribution of the mineral.  The program was set to analyze sections in 
25% increments from centroid (a).  Even distribution of bone in ossicles produced by 
micromass seeding showed no significant differences in bone % between regions (b).  
Ossicles generated by scaffolds seeded through filtration showed a significant difference 
in mineral from the periphery (75-100%) to the core (0-25%);  p<0.001. The amount of 
mineral content in 0-25th% of the micromass ossicles was significantly greater than the 
filtered ossicles (p=0.0213), while the opposite is true for the periphery (p=0.0311).  
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Chapter 4 
Connexin 43 as a signaling platform for increasing the volume and spatial 
distribution of regenerated tissue 
4.1 Introduction 
Cell-to-cell communication, via intracellular chemical and mechanical signals, is 
critical to maintain tissue homeostasis 1, 2. Gap junction intercellular communication 
(GJIC) is the most direct way of achieving such signaling 3 and is particularly important 
to maintain synchronized and cooperative behavior of cells in three-dimensional tissue 4.  
As consequence, the absence of gap junctions has been linked with several debilitating 
diseases and tissue malformations, such as oculodentaldigital dysplasia, impaired heart 
function and certain types of cancerous tumors 5-10.  Of the 19 known gap junction 
subunits (connexins), connexin43 (Cx43) is the most prevalent 11.  The ubiquitous nature 
of this protein throughout most vertebrate cell types makes it a potent signaling platform 
that enables cells to communicate directly and also distribute secondary messengers 
initiated by other biological cues and stimuli 12-21 that play a role in cell differentiation 
and tissue formation22-26, such as Bone Morphogenetic Protiens (BMPs) and PHT.   
However, characterization of these stimuli has been limited to in-vitro assessment of cells 
in a two-dimensional monolayer, and may misconstrue the real impact of these factors in 
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three-dimensional settings 27. Limitations in cell-to-cell communication in 3D may hinder 
the coordinated behavior of cells, and inhibit proper passage of secondary messengers 
and eventual tissue formation.  Overexpressing Cx43 as a conduit to improve GJIC can 
be a platform to enhance the distribution of signals among cells in a 3D setting and, 
therefore, be a powerful strategy in both cell-based strategies and targeted delivery as 
treatments to boost cell-to-cell communication.  Our research, therefore, may have a 
significant impact in the regeneration of tissue de-novo and in-vivo as well as therapies 
for diseases in 3D tissues characterized by compromised cell-to-cell communication, 
such as some forms of cancer and heart disease 28, 29. 
In this study, we focus on the specific effects of Cx43 as a platform to enhance 
gap junction intercellular communication in 3D.   Because of its inherent limitation in 
producing spatially uniform 3D mineralized tissue equivalents, bone is used as a model 
tissue.  Such limitation is in large part prompted by the early formation of hard tissue in 
the periphery of tissue engineered bone ossicles which prevents tissue regeneration in the 
core 30, 31.  In order to examine the role of enhanced GJIC in tissue engineering, we 
investigated the effects of stable Cx43 overexpression in bone marrow stromal cells 
(BMSCs), a pluripotent somatic stem cell, by transducing them with a lentiviral vector 
encoding the Cx43 gene (LVCx43GFP) and seeding them in 2D and 3D cultures.  
Enhancing gap junction function in BMSCs is attractive because these cells express a low 
level of Cx43 32, 33 relative to osteoblasts, and have the ability to differentiate into bone, 
given the proper biological cues 32, 34.   
Both the effects of increased GJIC alone and in combination with an osteogenic 
stimulus on BMSC differentiation, in 2D and 3D cultures, into an osteogenic phenotype 
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in-vitro and bone formation in-vivo, were examined.   Toward this end, we chose to 
induce bone formation by both transducing BMSCs with Cx43, and co-transducing Cx43 
gene-modified BMSCs with an adenovirus encoding the gene for BMP7 35-37.  BMP7, is a 
powerful osteoinductive agent that enables differentiation 36-39 and does not modulate the 
expression of Cx43 40.  Cell-to-cell communication and osteogenic differentiation were 
assessed in both a 2D monolayer and 3D cultures.  In 3D cultures, differentiation and 
GJIC were further assessed the surface and the inner core of 3D scaffolds. Because of the 
differences in cell numbers between 2D and 3D cultures, intracellular communication and 
mRNA obtained from the cells was normalized.  In-vivo regeneration of tissue by cells 
overexpressing Cx43 was quantified and compared to tissue regenerated by BMSCs.  The 
differences were assed as a function of total bone volume fraction of bone regenerated 
after 4, 8, 12 weeks of transplantation as well as quantitatively assessing for differences 
in the spatial uniformity of the tissue.  The same in-vivo studies were performed in 
BMSCs overexpressing BMP7 and co-transduced with Cx43 and BMP7. 
Our experiments aim to answer two critical questions in applied biology.   First, 
can overexpression of Cx43 enhance cell communication throughout three-dimensional 
structures?  Secondly, can such enhanced communication lead to higher and more 
spatially distributed amounts of engineered tissue?    Based on our data, we propose that 
enhanced GJIC, via genetically engineering cells to overexpress Cx43, as a novel 
platform to produce spatially distributed communication in 3D, and achieve larger 
volumes of evenly distributed tissue equivalents.  These results have a major impact in 
the strategic design of cell-based tissue engineering, and may be significant to directed 
therapies that aim to enhance cell communication in 3D tissue.    
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4.2 Materials and Methods 
4.2.1 Viral Vector Production  
Vectors encoding Cx43 and BMP-7 were produced by the University of Michigan 
Vector Core employing standard transient transfection methods to produce replication 
incompetent viral vectors.  The development and production of the lentiviral vector 
encoding Cx43GFP has been previously described 41.  The vector system was based on 
the human immunodeficiency virus Type 1 (HIV-1) and the four plasmids required for 
vector production were kindly supplied by Professor Inder Verma from the Salk Institute, 
San Diego USA. The development and production of the adenovector encoding BMP7 
under the transcriptional control the human CMV promoter has been previously 
described 37.  Empty vectors devoid of a transgene and vectors encoding GFP were also 
produced for lentivirus (LVMT, LVGFP) and adenovirus (ADCMVMT), and employed 
as controls.  A seven base pair deletion mutant (LV Cx43∆7) that produces connexin 
structures but is disabled from engaging in GJIC was used as a dominant negative control 
group. 
4.2.2 Culture and Transduction of BMSCs 
Five-week old C57BL/6 mice were used to isolate bone marrow cells from the 
femoral, tibial and humeral cavities (six bones per animal), as previously described 42. 
BMSCs mixed with enriched minimum essential medium (α-MEM; Gibco Laboratories, 
Grand Island, NY) containing 10% fetal bovine serum (FBS) (Gibco) and antibiotics (100 
µg/ml penicillin G and 100 IU/ml streptomycin) at 37°C in 5% CO2/95% air) were plated 
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at a density of 2.25 million cells per T75 flask.  Cells were passaged twice before 
transduction.  For LVCx43GFP, LVGFP, and LVMT transductions, lentiviral vector with 
a titer of 106 transducing units/ml was used on day 3-4 of sub-culture. Transduction was 
carried out in the presence of 8 µg/ml of protamine sulfate to enhance the transduction 
efficiency.  Five ml of filtered vector-containing enriched α-MEM was added to the cell 
cultures for approximately 16 h (transduction phase), followed by replacement of media 
with fresh media for 6-8 h (recovery phase).  The cells were exposed to three cycles of 
transduction.  After 12 days of incubation, transduced BMSCs were examined under 
fluorescent microscopy to determine transduction efficiency through GFP fluorescence.  
Ten random fields per well were photographed and transduction was measured as the 
average fraction of fluorescent cells relative to total cells in the field. Transductions with 
ADCMVBMP7 and ADCMVMT were performed as previously stated 38.  Briefly, for in-
vitro transduction of BMSCs, adenovirus at the desired titer to achieve a multiplicity of 
infection of 200 plaque forming units (PFU) was added to cells in serum-free α-MEM. 
After 4 h, FBS was added to a final concentration of 2% and medium was kept on cells 
for an additional 24 h. 
4.2.3 Western Blot  
Western blot analysis was performed using mouse anti-Cx43 with GAPDH as a 
sample loading control.  Cells were lysed in lysis buffer (66 mM Tris-HCl, 5 mM EDTA, 
5mM EGTA, 10 mM Na-phosphate, 5 mM NaF, 5 mM Na3VO4, 2.5mM PMSF, 10 mM 
NEM, 2% SDS, 0.5% Triton X-100, pH 8.0).  Loading protocols were followed from the 
western blot kit (Zymed).  Blots were incubated in 1% nonfat dry milk solution in PBS 
overnight with gentle shaking.  The following morning, blots were washed 3 times with 
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PBS, incubated with primary antibodies for 2.5 hours. The resulting bands were 
quantified by densitometry (ImageQuant, GE), and were normalized to endogenous 
GAPDH expression.  In order to quantify the total Cx43 expression in Cx43-GFP 
transduced cells, the 74kDa band (sum of Cx43 and GFP fusion protein) was analysed.  
The results are reported as a ratio, with the denominator being the endogenous Cx43 
expression in non-transduced BMSCs.  Experiments were performed in triplicate (n=3) 
and were done 1 week after the end of transduction.  One-way ANOVA was performed 
on the ImageQuant data for band intensity to determine whether the levels of Cx43 
expression were significantly different (p=0.05) between cell groups. The average of the 
total Cx43 or Cx43-GFP fusion gene was normalized against GAPDH, for BMSCs, 
BMSCs transduced to overexpress Cx43-GFP, and BMSCs transduced to overexpress 
GFP.  All values were later normalized to the expression of BMSC Cx43 content.   
 
4.2.4 2D and 3D Cell Culturing 
For 2D cultures, 1 million cells were cultured in 6-well plates (Sarstead) and 
grown to 90% confluence. 3D culture experiments were performed by seeding cells in 
gelatin sponges (Gelform; Pharmacia & Upjohn, Kalamazoo, MI).  Two experiments 
were done:   (1) overall assessment of cell to cell communication and differentiation in 
3D construct relative to 2D cultures, (2) assessing the differences in these parameters 
between the surface and core regions of cell seeded 3D scaffolds.  In the 3D studies, the 
gelatin sponges were designed to have 3x3x3mm3 dimensions.  Studies that examined 
peripheral vs. core communication and differentiation were performed by entrapping two 
sponges in 96 well plates (corning), one on top of the other.  The thickness of the top 
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sponge was set at 0.5mm, compared to 2.5mm for the bottom sponge.   Cell-gelatin 
constructs completely covered the side of the plates.  The bottom sponge is taken to be 
the core section of the scaffolds as the walls of the well plate serve to block any flux or 
communication from the bottom or sides. All sponges were pre-wet in α-MEM, and air 
bubbles removed by applying gentle pressure on the sponge between two pieces of sterile 
filter paper. 2.5 million cells were collected, suspended in 50 µl medium, and loaded onto 
each sponge by capillary action.  Both 2D and 3D cultures were induced to differentiate 
with osteogenic media (88% MEM-α media, 9%  Fetal Bovine Serum, 1% Pen/Strep, 1% 
100x β-Glycerophosphate, 1% L-ascorbic acid-phosphate, ~ 0.05%  Dexamethasone) one 
day after culturing.  After culture time, the gelfoam-cell constructs are removed from the 
well-plate and separated for analysis of both surface and core cells. 
 
4.2.5 Dye transfer studies of Cx43 
Fluorescent dye transfer studies were performed to assess gap-junctional 
intercellular communication (GJIC).  Calcein-AM (10um, gap junction permeable, 
molecular probles) and Vybrant-DiI (membrane tracker, molecular probles) were used to 
label donor cells grown to confluence in a 12-well plate. As a negative control, 50uM of 
the gap junction uncoupler alpha-glyccirrhetinic acid (AGA) was used (Sigma). Donor 
cells were added to potential recipient cells, cultured to confluence in monolayer (12-well 
plates) or in 3D constructs (Gelfoam®, 8 days), at a ratio of 1:8.  After 5 hours, cells 
were harvested by trypsinisation for quantitative assessment of GJIC by flow cytometry 
(BD Biosciences FaCSCalibur), of homogeneous samples. Dye studies were performed 
on all cell types in the experimental groups, at a sample size equal to six (n=6) wells or 
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gelfoam constructs. A 2-way ANOVA was used to determine significant differences 
between 3D and 2D realms and cell type.   Two tailed student t-test was applied to 
determine significant differences between cells in surface of the 3D scaffold (outer 
0.5mm) and core (inner 2.5mm) of the 3D constructs  (p =0.05). 
4.2.6 Real-time PCR Analysis 
Real-Time PCR was used to detect the expression of two bone differentiation 
markers, alkaline phosphatase (ALP) and osteocalcin (OCN) on BMSC control groups 
and cells modified with Cx43 and/or BMP7. PCR was performed using ABI Prism 7700 
sequence detection system.  Primers and TaqMan probes were designed using Primer 
Express design software (ABI).  The primer sequences utilized was as follows: OCN, 
forward 5'-CCAGCGACTCTGAGTCTGACAA-3', and reverse 5' -
CCGGAGTCTATTCACCACCTTACT-3'.  Cells seeded scaffolds or in 12 well plates 
were trypzinized after 2, 8, and 16 days, to remove cells and the total RNA was extracted 
(Trizol; invitrogen Corp). The RNA was purifed (RNeasy, Quigen) and treated with 
DNAse I.  Cycling conditions were as follows:  50C for 2 minutes and 95C for ten 
minutes, followed by 50 cycles of 95C for 15 seconds and 60C for 1 minute.  No-
template control analyses were run for each primer set and 18s rRNA (ABI) endogenous 
control was run for each sample.  Analysis was performed by first setting an appropriate 
standard threshold level in the linear part of the reaction for each primer.  The crossing 
value of this threshold was determined (Ct) for each sample.  Using the manufacturer’s 
protocols (ABI Prism 7700 Sequence Detection System, User Bulletin #2), mRNA 
expression levels for each sample/primer were normalized to endogenous  rRNA 18S 
levels and the results were reported as a fold change relative to the OCN expression of 
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BMSCs (day 2).  All reactions were performed in quintuplets. Two 1-way ANOVAs 
were used to determine significant differences as a function of dimension (3D vs. 2D) 
and cell types.  Differences between surface (peripheral) segments and core (bottom) 
segments were assessed with a two-tailed student t-test using SigmaSTAT version 3.1. 
4.2.7 In-vivo transplantation 
Surgery was performed in nude mice (nu/nu) by transplanting gelatin scaffolds 
(3×3×2 mm3) seeded with 2x106 cells.  The mice were anaesthetized by an intraperitoneal 
injection of 1 mg/10 g ketamine and 0.1mg/10 g xylazine.  A 3 cm longitudinal incision 
was made overlying the spine.  Four subcutaneous pockets were made using blunt 
dissection through the minimal subcutaneous tissue of the mice. In each pocket, one of 
the prepared cell-gelfoam specimens (BMSC, BMSC-Cx43, BMSC-BMP7, BMSC-
Cx43-BMP7, BMSC-LVMT, BMSC-ADCMVMT) or acellular gelfoam specimen was 
implanted.  The cell-gelfoam specimens were assigned randomly to each pocket.  The 
incision site was closed with wound clips or sutures.  The mice were allowed to recover 
on a recirculated heated water pad.  Recovery from anesthesia was monitored closely.  
Four, 8, and 12 weeks after transplantation, mice were euthanized by cervical dislocation.  
Ossicles were extracted and stored in 70% ethanol until analysis.    
4.2.8 Micro-CT 3D image acquisition and analysis 
Ossicles were scanned on a high resolution cone beam micro-CT system 
(Enhanced Vision Systems (now GE Healthcare Preclinical Imaging), London, Ontario, 
Canada). The x-ray source voltage and current were 80 kVp and 80µA, respectively. To 
reduce the potential for beam hardening artifact, the x-rays were passed through a 0.2mm 
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Al filter immediately upon exiting the source and the specimens were immersed in dH2O 
during the scanning process. Projection images were acquired over 198 degrees using 2x2 
binning and an exposure time of 1100 ms, and four frames were averaged for each 
projection to improve the signal to noise ratio. The projection data was then corrected and 
reconstructed using the Feldkamp cone-beam algorithm to create three-dimensional 
images with an isotropic voxel size of 18µm43.  The scanner was calibrated once daily 
using a phantom that contained air, water and hydroxyapatite.  Bone volume fractions 
(BVF) were determined by using a MatLab program designed to integrate all grayscale 
voxels above a particular threshold.  To determine the overall volume of the ossicles, the 
program determined the perimeter of each 2D µCT slice by tracing the outer edge. The 
program then integrated all the perimeters to determine the 3D surface area, and the 
number of voxels inside the surface defined the total volume.  High density voxels 
outside of the 3D surface and unattached to the ossicle were discarded, while voxels 
inside were evaluated at the specified thresholds to determine the BVF, which was 
calculated as the number of voxels above the threshold relative to the total number of 
voxels.  Using this method, a threshold of 1100 was used to re-construct a rendered 
image of the ossicles and determine their distribution.   
A custom program was developed to determine the distribution of regenerated 
bone as a function of the distance to the geometric center of each ossicle.  Using the 2D 
Micro CT sections, the centroid was calculated with a MatLab script 44 and used as a 
frame of reference to divide the ossicles into regions.  Defining the centroid as the 0th 
percentile and the edge as the 100th percentile, boundaries were calculated by lines that 
radially pointed into the center from the edges.  Cortical bone was determined to be the 
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continuous bone formation in the periphery of the ossicle.  The program calculated this 
thickness by averaging the thickness at 10 degree increments from the geometric center 
of the ossicle (total 36 data points per ossicle).  Trabecular bone volume fraction was 
determined to be the remaining bone fraction normalized to the potential trabecular space 
(total bone volume - cortical bone volume).   
4.2.9 Histology and Morphological Analyses 
The ossicles were rinsed in water and then decalcified in 10% formic acid for 5 
days. After decalcification, the tissues were embedded in paraffin. 5 µm sections were 
made and placed on 10 slides with 3 sections per slide. The tissue was deparaffinized 
hydrated, and the first, fifth, and tenth slides were stained with H & E. Image Pro Plus 4.0 
was used to take pictures of the histological sections in order to observe the overall bone 
formation, cortical thickness, and trabecular-like bone formation.   
 
4.3 Results 
4.3.1 Characterization of Cx43-GFP modified BMSCs 
Transfer efficiency of the GFP-Cx43 fusion gene was measured at 83% +/- 4% by 
assessing the number of GFP positive cells (Fig 1 B) relative to the total number of nuclei 
per given field two weeks after transduction.  Similar efficiency was attained when cells 
were co-transduced with AD-BMP7 and LVC-Cx43-GFP (85% +/-5%) and control cells 
with LVGFP (87% +-/-7%), indicating that the co-transduction did not alter the 
transduction efficiency of cells with Cx43 and that no differences in transduction 
occurred between Cx43-GFP and GFP containing lentivirus. A significant increase in 
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expression of Cx43 occurred when cells were transduced with LVCx43GFP (Fig. 1C).  
The total expression Cx43 in BMSCs transduced with Cx43-GFP was significantly 
higher (3.74 +/-0.49, p<0.001 against both groups) compared to the non-transduced 
BMSC group (1.0 +/-0.29) and the control LVGFP transduced group (0.89+/-0.11).    
4.3.2 Overexpression of Cx43 increases GJIC 
BMSCs transduced with Cx43 exhibited significantly higher transfer of Calcenin-
AM than BMSCs,  both in cells cultured in 6-well plates (2D) and gelfoam scaffolds (3D), 
relative to non transduced groups (p<0.001 for all, figure 2).  There was no significant 
difference between Cx43 and Cx43-BMP7 or between BMSCs and BMSC-BMP7 
transduced cells, suggesting that BMP7 does not modulate gap junction function.  Cells 
transduced with a seven base pair deletion Cx43 gene mutant (Cx43∆7) which enables 
proper docking of connexin hemichannels but inhibits GJIC, exhibited significantly less 
transfer than both BMSCs and BMSCs transduced to overexpress Cx43 (p<0.001).  The 
data suggests that Cx43 plays a prominent role in cell-to-cell communication, and 
inhibition or overexpression will lead to hindered or amplified GJIC, respectively.   
When cells overexpress Cx43 the percentage of cells that uptake calcenin in 3D 
cultures was significantly greater than the percentage of those that uptook calcenin in 2D 
cultures (figure 2b, p>0.001 in both Cx43 and Cx43-BMP7 vs. all other cells).  BMSCs 
and BMSCs transduced with BMP7 showed no significant difference in transfer fraction. 
Cells transduced with control vectors (LVMT, LVGFP, ADCMVMT, 
ADCMVMT/LVMT), showed no significant difference in GJIC from BMSC (data not 
shown).  The results support the hypothesis that overexpression of Cx43 enhances GJIC 
in 3D. 
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BMSCs, BMSCs transduced with BMP7, and BMSC-Cx43∆7, exhibited 
significantly less calcenin transfer in the core of the scaffold, relative to the periphery 
(Fig 2b; p (BMSCs) <0.002, p (BMP7) <0.001, p (Cx43∆7) <0.013).  However, cells 
overexpressing Cx43 exhibited similar GJIC transfer in the surface and core sections of 
the scaffold.  Our results imply that cell-cell communication is compromised in cells 
entrapped in the core of 3D tissue engineered equivalent and that overexpressing Cx43 is 
one potential solution to overcome this problem. Our data therefore suggests that 
overexpressing Cx43 provides a platform that enables a more amplified level of cell-to-
cell communication.  
4.3.3 Cx43 overexpression enhances overall and spatial distribution of 
differentiation markers 
Increased Cx43 expression in BMSCs was associated with significantly higher 
levels of osteocalcin (OCN) mRNA, relative to control groups (Fig 3a). Two days after 
differentiation was induced cells overexpressing Cx43 and Cx43-BMP7 exhibited 
significantly higher levels of OCN mRNA (p<0.001 against all groups) and no significant 
difference between them (p=0.692).  Cells overexpressing BMP7 only expressed higher 
levels of OCN than BMSCs (p<0.023), although significantly less than cells 
overexpressing Cx43 (p<0.001).  Similar trends were observed on the 8th day after 
differentiation was induced, although OCN expression increased 4-5 times compared to 
day 2, in cells overexpressing Cx43.  At day 16, cells overexpressing both Cx43 and 
BMP7 produced significantly more OCN mRNA (p<0.001, relative to all other cell 
groups, including cells overexpressing Cx43 only).  This data suggests a synergistic 
relationship between Cx43 and the stimulus provided by BMP7.  Cells overexpressing 
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the mutant Cx43∆7 produced significantly less OCN expression than all other cells.  in 
fact, Cx43∆7 overexpressing cells failed to produce significant levels of OCN mRNA at 
any time. Control vectors (LVMT, LVGFP, ADCMVMT, ADCMVMT/LVMT, data not 
showed), showed no significant difference in mRNA production compared to BMSC 
expression, suggesting that the transduction through lentivirus and/or adenovirus did not 
alter the expression or viability of the cells. 
Important differences were observed between 2D and 3D cultures in osteocalcin 
expression (Fig. 3b).  First, osteogenic differentiation as indicated by OCN expression 
was significantly greater in 2D cultures compared to 3D cultures in BMSCs (p<0.021), 
BMSCs overexpressing BMP7 (p<0.001), and all control empty vectors (data not shown).  
Levels of OCN mRNA in cells overexpressing Cx43∆7 were not significant in both 2D 
and 3D culture.  However, when cells overexpressed Cx43, there were no significant 
differences in OCN expression between the two and three-dimensional cultures, 
supporting the premise that 2D and 3D cultures are intrinsically different, and the results 
in one culture system do not necessarily translate to the other.  Furthermore, our results 
suggest that cell-to-cell communication may be a main reason for such as difference 
observed in the two culture systems, and that overexpressing Cx43 can mediate apparent 
differences in GJIC between the two systems.   
Both BMSCs and BMSC-BMP7 express significantly higher levels of OCN in the 
surface relative to the core of the scaffold (Fig 3c, p<0.001 for both). Furthermore, the 
effect of BMP7 is significantly neutralized in 3D, showing a 4 fold decrease in OCN 
expression relative to 2D monolayer and only a moderate increase over the BMSC group 
in 3D (p<0.092).  When Cx43 is overexpressed along with BMP7, the differences 
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between 2D and 3D are not present.  Combining this observation with the results showing 
that cells overexpressing Cx43 produce similar levels of OCN in surface and core 
sections of the scaffold strengthen the hypothesis that Cx43 is a potent signaling platform 
for 3D cultures that can create a spatially uniform distribution of differentiated cells.     
4.3.4 Cx43 Gene-Modified Cells Regenerated More Bone In-Vivo 
A qualitative comparison between bone formed from transplanted BMSCs (Fig 4 
a,b,c) and BMSCs overexpressing Cx43 (Fig 4.d,e,f) shows that overexpressing Cx43 led 
to more bone formation and an increased cortical thickness.  Bone regenerated by 
BMSCs, BMSCs overexpressing BMP7 and BMSCs overexpressing Cx43 exhibited a 
cortical-like barrier with enclosed marrow cavity.   However, bone formed from Cx43 
transduced cells exhibits a thicker cortex and a smaller amount of marrow. Ossicles 
formed from co-transduced cells produced large amounts of cortical and trabecular-like 
bone (Fig 4 j,k,l).  Bone regenerated from control groups transduced with LVGFP and/or 
ADCMVMT were similar to those of BMSCs, denoting no significant change due to 
vector transduction.   
The BVF of ossicles produced by transplanted BMSC-Cx43 cells was 
significantly higher at all time points than ossicles formed from BMSCs (p(4 
weeks)<0.021, p(8 weeks)<0.001, p(12 weeks) <0.003).  Ossicles formed from cells 
stimulated by BMP7 produced significantly higher BVF when Cx43 was overexpressed 
relative to the BMP7 only group (p(4 weeks) <0.033, p(8 weeks)<0.001, p(12 weeks)< 
0.001).  Co-transduced cells led to significantly higher BVF’s than all other groups at 8 
and 12 weeks (p<0.001 against all groups at both times). Control cell groups generated 
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volume fractions that were not significantly different from volume fractions generated by 
BMSCs at any time.   
Cortical thickness was significantly greater in ossicles formed from transplanted 
BMSC-Cx43 cells (Fig. 5b) compared to the BMSCs (p <0.001, for 4, 8, 12 week time 
points).  Similarly, bone regenerated by co-transduced BMSCs produced a thicker 
cortical-like periphery than ossicles generated by BMP7 (p<0.001, at 4 and 12 weeks).   
The trabecular-like BVF was significantly higher in ossicles formed with cells co-
transduced with Cx43 and BMP7 after 8 and 12 weeks of implantation (Fig. 5c).  In the 4 
week period, the BMSC-Cx43 group had significantly more trabecular-like bone 
formation than the BMSC group (p<0.001).  These differences were not observed at the 8 
week period (p<0.56), but were again evident in the 12 week time point (p<0.001).  In 
cells transduced with BMP7, cells overexpressing Cx43 exhibited significantly more 
trabecular BVF (p<0.001, at all time points).  Furthermore, the effect of the co-
transduction in bone in-growth was significantly greater when cells were co-transduced 
(p<0.001, against all other groups), suggesting a synergistic effect in the development 
and growth of bone.   
4.4 Discussion 
Our data demonstrates that Cx43 overexpression can be a platform to enhance 
cell-to-cell communication throughout 3-dimensional tissue and as a tool to regenerate 
tissue in-vivo.  Specifically, we demonstrated that cells expressing higher levels of Cx43 
exhibit higher GJIC, more osteogenic differentiation in-vitro and, when transplanted, 
form tissue of larger volume and more uniform spatial distribution. Using Cx43 as a 
signaling platform can have profound effects in both cell-based tissue engineering and 
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targeted gene therapy.  Tissue engineering will benefit from the production of higher 
volumes of more highly distributed tissue equivalents, while targeted delivery therapy 
can use Cx43 delivery to enhance GJIC in communication incompetent cells within living 
3D tissue.   Our studies have significant impact in applied biology and will likely 
promote further investigation in the regeneration of other 3D tissues.   
To achieve higher cell to cell communication, we genetically engineered cells to 
over-express the gap junction protein Cx43 (Fig 1). Disruption of gap junctions formed 
by Cx43 in bone forming cells results in compromised osteogenic differentiation and 
deficiencies in matrix mineralization and bone formation. 13, 45-48.  However, the role of 
overexpressing Cx43 in progenitor cells as a strategy to enhance 3-dimensional tissue 
regeneration has not been examined.  In this investigation, we have shown that 
overexpression of Cx43 and increased gap junction function (Fig 2), leads to higher cell 
differentiation in-vitro (Fig 3) and more in-vivo bone formation (Fig 4).  Also, bone 
regeneration in the core of the scaffolds was achieved (Fig 5), which suggests a role for 
enhanced GJIC in the homeostatic environment necessary for full tissue regeneration.  
These finding suggest that enhanced GJIC enables cues to distribute more effectively and, 
cells when induced by the environment, can differentiate and produce higher quantities of 
tissue. 
Regeneration of large and uniform volumes of 3D tissue equivalents has been 
elusive.  When seeded into a 3D ECM analogue, cells in the periphery thrive and 
differentiate, while those in the core of the scaffold are less viable and exhibit 
compromised differentiation 30, 31. This limitation produces incomplete regeneration of 
tissue, making it less clinically relevant 49-52.   Therefore, there is a need to generate 3D 
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in-vitro models for bone engineering, in order to create strategies and study mechanisms 
that will help regenerate clinically viable tissue equivalents.   
To gain insight into the ability of increased GJIC to enhance spatial distribution of 
differentiation we cultured cells in monolayer (2D) and scaffolds (3D), and assessed 
differences in GJIC and osteogenic differentiation between 2D and 3D cultures and 
between the surface and inner regions of 3D cell cultures. Cells overexpressing Cx43 
exhibited higher GJIC in 3D culture relative to the 2D monolayer, whereas control cells 
and cells overexpressing only BMP experienced similar levels of GJIC.  Cells 
overexpressing Cx43 exhibited similar levels of OCN expression (relative to BMSCs) in 
2D and 3D cultures.  These results contrast the decreased levels of OCN mRNA in 
BMSCs and BMSCs overexpressing BMP in 3D cultures when compared to a monolayer.  
Our data points out to the greater importance of GJIC in 3D constructs compared to a 2D 
monolayer (Fig 3b). Overexpression of Cx43 enables greater GJIC in 3D and has a high 
impact on the differentiation of cells, suggesting that more gap junction channels are 
formed when cells are in a 3D setting as the cell-cell surface contacts increase, enabling 
higher cell-cell communication when sufficient channels are formed.   Secondly, the 
results suggest cell-to-cell communication is an essential component in the observed 
differences between 2D and 3D settings (Figs 2b, 3b).  Inhibited cell-to-cell 
communication may enable cells to act independently and un-synchronized, which may 
affect tissue development and homeostasis. Further insights into the impact that GJIC has 
in 3D cultures is derived when the core sections of 3D cell-scaffold constructs are 
compared to surface sections (Figs 2c and 3c).   Cells that do not overexpress Cx43 
exhibit significantly less GJIC and differentiation in the core of the 3D cultures, 
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contrasting cells overexpressing Cx43, in which there is no significant difference in GJIC 
and differentiation between the core and surface, suggesting that enhanced GJIC enables 
a more even distribution of cues and differentiation in 3D.   
The in-vitro results clearly demonstrate the effects in osteogenic differentiation as 
a function of enhanced Cx43 expression.  In-vivo, tissue regenerated by cells 
overexpressing Cx43 had a larger quantity of bone in-growth relative to control groups 
(Fig 4 a-l).  The larger production of trabecular-like bone ingrowth, characterized by 
regeneration of bone in the core of the ossicle, and a thicker cortex suggest that when 
differentiation and bone formation are occurring, the higher level of cell-to-cell 
communication enables cells to act in a synchronized manner, thereby allowing full 
development of tissue throughout the scaffold.  The significant increases in total bone 
volume fraction and distribution of tissue in bone formed from cells overexpressing Cx43 
relative to that formed from BMSCs suggest that Cx43 can be a powerful tool to 
regenerate 3D tissue in-vivo.  
GJIC also enables the distribution of signals ignited by a secondary stimulus, 
whether electrical, mechanical or biological in nature, between neighboring cells 14. To 
test the effect of higher GJIC in tandem with another stimulus, cells were induced to 
overexpress bone morphogenetic protein 7 (BMP7).  This growth factor was chosen 
because it has potent osteoinductive effects but does not modulate the expression of 
Connexin 43 40.  Our results showed that enhanced GJIC increased the effect of BMP7, 
suggesting that the overexpression of Connexin 43 synergistically enhances the effects of 
other stimuli, by enhancing the distributed differentiation potential of cells throughout a 
3D culture (Fig 3) and volume fraction of regenerated bone (Figs 4,5) over cells 
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overexpressing BMP7 alone.  The experiments with BMP7 are an example of a platform 
that could potentially be extended to other tissues by using connexin 43 with other 
growth factors or stimuli that enhance the regeneration of a particular tissue of interest.   
Combined, our findings suggest that increasing gap junction intercellular 
communication via overexpression of connexin 43 can be, on its own, a powerful tool to 
overcome limitations inherent in cell-to-cell communication and regeneration of tissue in 
3D, and can complement the effect of another agent or stimulus; leading to regeneration 
of larger volumes and more uniform tissue. Our strategy may be broadly applied to a 
wide range of cells and 3-dimensional tissues with the aim to enhance cell-cell 
communication enabling normal development and homeostasis.  This concept can also be 
applied in future therapies to combat many types of cancer 9.  As a preventive measure 
for malignant cancerous tumors, Cx43 gene delivery can be targeted on cancerous and 
pre-cancerous cells, which are characterized for becoming GJIC deficient.  Ultimately, 
our approach may be a fundamental component overcoming the longstanding problem of 
inducing synchronized cell behavior in 3D cultures of cells or tissues and developing 









Figure 4-1 BMSCs are highly transduced with Cx43-GFP 
Expression of the Cx43-GFP gene in transduced BMSCs was observed under a phase 
contrast (a) and fluorescent microscope for GFP expression (b). The expression of Cx43-
GFP, Cx43, GAPDH and GFP was also measured using western blot analysis (c), 
Quantification of the band intensities showed a significant increase (3.74 +/-.49, p<0.001, 




Figure 4-2 GJIC in BMSCs, as measured by Calcenin-AM transfer is enhanced 
with Cx43 overexpression:    
The transfer fraction was measured for groups cultured in 2D monolayer and 3D cultures 
(a).  Cells overexpressing Cx43 (Cx43 and Cx43 BMP7) had a significantly higher 
transfer fraction than the control groups (BMSC, BMP7; p<0.001), and the negative 
control group (Cx43∆7; p<0.001).   Transfer was enhanced in 3D when cells were 
overexpressing Cx43, relative to 2D culture.  Groups that did not overexpress Cx43 
showed significant decreases in dye transfer from the top surface of the construct, to the 
core section, whereas no significant difference was evident in groups overexpressing 




Figure 4-3 Cx43 overexpression is associated with higher levels of OCN mRNA 
expression at all times 
Overexpression of Cx43 had significant effects on OCN expression, when comparing a 
2D monolayer to a 3D cell culture (b).  The normalized values of OCN mRNA where 
significantly higher in two dimensions, for cells that did not overexpress Cx43, while 
cells that overexpressed Cx43 exhibited no significant difference between 2D and 3D 
cultures.  This result suggests that 2D cell culture models may not translate to 3D culture, 
and that Cx43 overexpression may be a tool to mediate those differences.  Surface vs. 
core studies (c) support this conclusion, suggesting that cell-to-cell communication in the 
core regions can be enhanced.   Cx43 overexpression produces evenly distributed 
differentiation throughout the 3D culture, providing a tool to regenerate larger and 
uniformly distributed tissue equivalents. Significant increases are indicated by * = 




Figure 4-4 Micro CT renderings and histological sections of ossicles regenerated 
following subcutaneous transplantation of BMSCs.  
The micro CT renderings exhibited differences in patterns of bone produced from 
BMSCs and BMSCs transduced to overexpress Cx43 (a-l).  BVF is quantified to assess 
for these differences (m).  Cells overexpressing Cx43 (d-f) regenerate larger volumes of 
tissue compared to BMSCs.   Bone regenerated by BMSCs (a-c) is characterized by a thin 
periphery of bone tissue.  When Cx43 is overexpressed (d-f), ossicles have both thicker 
peripheral bone formation and more bone regeneration in the core of the 3D construct.  
Ossicles generated from BMP7 transduced cells (g-i) are characterized by a thin cortex 
(although larger than BMSCs), while tissue regenerated with co-transduced cells (j-k) 
exhibits large amounts of bone in-growth and overall bone regeneration. Histological 
sections validate the CT renderings.  The volume fractions (m) reflect a significant 
increase in bone regeneration in all transduced groups over BMSCs.  Tissue regenerated 
by cells overexpressing Cx43 has significantly higher BVF than the ossicles regenerated 
from BMSCs at 4, 8 and 12 weeks (p(4 weeks) <0.032, p(8 weeks)<0.001, p(12 
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weeks)<0.003).  When cells were stimulated with BMP7, the co-transduced group 
produced a significantly higher BVF, relative to the BMP7 transduced group (p<0.001 in 
both 8 and 12 week periods).  Finally, co-transduced groups produced significantly 
higher BVF than any other group in the 8 and 12 week period, suggesting a synergistic 
relation between Cx43 and BMP7.  Significant increases are indicated by ** = BMSC, 
*** =Cx43, # =BMP7.  Horizontal bars represent groups that are not significantly 















Figure 4-5 Cortical-like thickness and trabecular-like bone volume fraction of 
tissue engineered bone. 
CT data files were analyzed using a custom topological MatLab program that quantifies 
both the average cortical thickness and trabecular-like BVF (a).   Cx43 transduced cells 
produced an average cortical thickness that was significantly greater (p<0.001, for all 
time points) than the cortical thickness of bone produced by BMSCs (b). The trabecular-
like bone volume fraction (c) was significantly greater in bone regenerated from cells 
containing Cx43 as well when compared to BMSCs (p(4 weeks)<0.001, p(12 
weeks)<0.001) . Co-transduced cells had significantly larger fraction of trabecular-like 
bone at the 8th (p<0.001) and 12th (p<0.001) week than all groups .  Significant increases 
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5.1 General Conclusions 
Our experiments examined strategies to enhance the regeneration of bone, both 
exogenously (cell seeding and biomimetic scaffolds) and by endogenously 
overexpressing factors in BMSCs that would enhance bone formation (Cx43).  
Specifically addressed in this thesis is the role of enhanced cell-cell communication, in 
the form of gap junction intercellular communication (GIJC), as a tool for bone 
regeneration.  Our results demonstrated significant increases in tissue regeneration, using 
both endogenous and exogenous strategies, which may have a powerful impact in the 
clinical setting.  
As part of the experiments performed, we first validated a threshold range to 
utilize for analysis of tissue engineered bone ossicles (Chapter 2).  Our threshold range 
was rigorously determined using imaging and ashing techniques to quantify tissue 
engineered bone in (a) Hounsfield Units (HU),  (b)  % of bone HU,  and (c) Bone Mineral 
Density (mg/cc) (1000-1300,  24.2-31.5%, 25966.6- 33799.5 mg/cc, respectively).  This 
threshold should provide some standardization and consistency for characterization of 
 128
tissue engineered bone.  These threshold values were used as a guideline to compare 
tissue engineered bone throughout the experiments performed in this thesis. 
First we addressed the question of altered initial conditions, in the form of cell 
seeding and surface chemistry, to increase the amount of tissue engineered bone (Chapter 
3).  The alternative seeding strategies developed here (filtration and micromass seeding) 
aimed to overcome the limitations observed with the commonly used static seeding 
techniques in tissue engineering. Cell density, cell-substrate adhesion and, cell-cell 
communication were assessed, although other factors, such as nutrient and byproduct flux, 
cell-cell adhesion, mechanical loading, and migration, were considered in the design of 
these strategies.  Micromass and filtration seeding led to significant increases in GJIC, 
osteogenic differentiation, and amount and spatial distribution of regenerated bone in-
vivo.  The outcomes attained by altering initial cell seeding conditions are powerful in the 
clinical context; namely, by altering cells initial positioning, cell-to-cell communication, 
and density in 3D scaffolds, higher amounts of tissue can be regenerated.  Clinically, the 
micromass principle may have a more powerful impact in larger defects, using larger 
scaffolds, as different arrays of micromasses can be created with the aim to regenerate 
full tissue equivalents. Because the micromass is a localized strategy of highly dense 
clusters of cells, these can be strategically placed within the scaffold to maximize cell 
viability, nutrient flux, and tissue regeneration.  With the aid of both mathematical 
modeling and experimental data, the location and size of the micromasses can be 
arranged to optimize outcomes in-vitro and in-vivo. Furthermore, it is likely that the 
optimal array of micromasses would vary as a function of scaffold geometry, 
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environment, cell type, and tissue.  The resulting models would provide an element of 
flexibility that optimizes tissue regeneration under different circumstances. 
Both filtration and micromass strategies are simple and inexpensive alternatives to 
other strategies aimed to enhance tissue formation, such as addition of inductive agents 
and genetic engineering.  Based on the simplicity of these techniques, they should be 
implemented over the traditionally employed static seeding modality.   
Template chemistry was also assessed as an initial and time dependant exogenous 
strategy to regenerate tissue.  Specifically for bone, we demonstrated that a biomimetic 
scaffold, rich in calcium/phosphate, serves as a better template than an organic template 
to enhance osteogenic differentiation in-vitro and regenerate higher volumes of tissue 
engineered bone. However, our data shows that mineralization of the substrate does not 
enhance overall cell adhesion, and GJIC as hypothesized.   Two main factors may have 
influenced these results.  First, although mineralization was achieved using the simulated 
body fluid (SBF) procedure (Chapter 3), complete scaffold mineralization was not 
attained.  Therefore, the current mineralization procedure may have not been optimal.  
Because of the low percentage of mineral, the seeding effect was the dominant factor in 
adhesion.  This is evident in the static seeding technique, where mineralized templates 
exhibited significantly higher adhesion than the PLGA substrate. Thus, the mineral did 
have a significant effect in cell adhesion, when the novel techniques were not employed, 
indicating that more mineral may enhance adhesion.  Efforts should be made to design a 
mineralization technique, perhaps through perfusion or filtration that will enable the 
scaffolds to mineralize at higher percentages.   
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A second reason for the observed effects is the time dependent release of ions 
from the substrate to the solution.  The release of ions, such as calcium and phosphate,  
may have an impact on differentiation and regeneration of tissue, but may not have a 
significant impact in cell adhesion.  Although one would expect that a higher 
concentration of secondary messengers, such as Ca++, would lead to higher GJIC, our 
experiments were carried out at early times, where the dissolution effects of the substrate 
may have been negligible.  Experiments (Shin et al) have shown that dissolution of 
mineral in scaffolds occurs at later times. Future experiments should examine GJIC at 
different times, including those in which the mineralized scaffolds show higher 
dissolution rates. 
As an endogenous strategy, we enhanced osteogenic differentiation and in-vivo 
bone formation to by genetically altering BMSCs to overexpress the gap junction forming 
protein, Cx43.    Such overexpression enhanced cell-to-cell communication, as measured 
by calcenin-AM transfer, in a 2-dimensional monolayer and 3D cell cultures.  Therefore, 
transduction via a lentivirus containing the Cx43 gene is an effective way to enhance 
communication in GJIC in areas of limited cell-to-cell communication.  Coupled with the 
inability to communicate when BMSCs overexpressed a mutant Cx43 gene that inhibits 
GJIC, our results indicate that GJIC is an important and essential component to tissue 
regeneration, and can be augmented artificially to enhance such communication.   
Because GJIC mediated by Cx43 allows the transfer of molecules as large as 1KD 
in size, these conduits are the main modes for transfer of ions, metabolites and, secondary 
messengers that affect signaling and prompt signaling cascades.  As an example, 
osteocalcin transcription is prompted by the passage of secondary messengers through 
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gap junctions that enable phosphorylation of the Sp1 transcription factor. When GJIC is 
high, phosphorylation of Sp1 is significantly greater than when cells exhibit low GJIC. 
Many of these messengers are a function of the local external environment in which the 
cells are present.  For tissue engineering purposes, this is an important component, as the 
local environments of cells in the periphery (exposed to nutrients) and those entrapped in 
the core of the constructs may be significantly different.  Enabling higher cell-to-cell 
communication may help transfer important secondary messengers in bone formation, 
such as calcium, ATP and insitol triphosphate. Such communication may overcome the 
limitations exhibited by some cells in less than optimal environments, to differentiate and 
regenerate tissue.    
As a tissue engineering strategy, enhanced GJIC can also be used in tandem with 
another agent, such as BMP 7, to increase the overall effect of the agent and enhance 
tissue formation and uniformity of distribution. When BMP 7 binds to type I receptors in 
the cell membrane, it enables a cascade of secondary messengers to be released inside the 
cell.  These messengers trigger transcription of proteins that induce differentiation and 
can be transferred to neighboring cells through the conduits formed by the docking of 
Cx43 enabled gap junctions.  Augmenting the communication enables the secondary 
messengers to reach cells that may have not been exposed to the stimuli. This dynamic 
allows transcription mechanisms to develop in cells that prompt differentiation, which 
leads to tissue formation.  Therefore, BMP 7 and gap junctions generated by Cx43 work 
synergistically when BMP 7 prompts secondary messengers, such as calcium and other 
transcription factors,  that can be distributed through gap junctions.   
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The overexpression of Cx43 (with or without BMP 7) also enhanced the 
distribution of regenerated tissue, suggesting that cell-to-cell communication is important 
for effective tissue regeneration in the core of 3D bone ossicles.  Our in-vitro data 
comparing the osteogenic differentiation of cells in the surface and core regions of a 3D 
construct supports this conclusion; when Cx43 was overexpressed, cell communication 
and osteogenic differentiation were enhanced in the core regions, relative to BMSC 
control groups.  Furthermore, we showed that GJIC plays a greater role in 3D compared 
to a 2D monolayer.  Communication between BMSCs is limited to a greater extent in 3D 
cultures.  However, when BMSCs overexpress Cx43 both 3D and 2D cultures have 
similar transfer efficiencies.  Because homeostasis is such an important component of 
tissue formation, we speculate that enhancing GJIC enables the population of cells seeded 
in the 3D construct to have a higher level of coordination, enabling more spatially 
distributed tissue regeneration.  Because of the ubiquitous nature of Cx43, our strategy 
could be applied to different tissues, with the aim of solidifying such overexpression as a 
powerful mechanism to enable higher cell-to-cell communication during differentiation 
and tissue formation. Also, these findings are not limited to tissue engineering, as they 
can also be applied to targeted gene therapy, such as cancer therapy, and development of 
3D culture model systems that are highly coordinated.  
The findings from this thesis propose important and novel strategies for the 
regeneration of 3D tissue engineered bone that can have an immediate impact in the 
clinical setting.  We have presented three exogenous strategies (micromass seeding, 
filtration seeding, mineralized template) and an endogenous one (overexpression of 
Cx43) that significantly enhance cell differentiation and bone regeneration.  In both 
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exogenous and endogenous strategies, it was shown that increased GJIC enhanced 
differentiation, bone regeneration, and distribution throughout the engineered tissue.  
 
5.2 Future work 
In addition to the combination of endogenous and exogenous strategies to 
regenerate larger volumes of tissue, two main directions should follow the results 
presented in this thesis.  First, it is important to examine the effects of other exogenous 
parameters, such as nutrient flux and migration, in tissue regeneration.  These parameters 
were taken into consideration when designing the seeding strategies and their specific and 
isolated roles in bone formation should be understood.   Secondly, investigate both the 
mechanistic aspect of GJIC and the potential applications that expand outside the realm 
of tissue engineering, such as targeted delivery and cancer therapy. 
Micromass and filtration seeding were proposed (Chapter 2) because the potential 
to take advantage of several factors believed to play a role in tissue formation.  Of these 
factors, the effects of osteogenic differentiation and bone formation due to migration and 
effect of nutrient flux should be examined next.  The ability for nutrients to flow in and 
byproducts out may be a dominant factor with respect to cell viability while cell 
migration may dictate osteogenic patterns and distribution of bone.   
Migration may play an important role by setting a gradient of differentiation that 
is that enables differentiation to occur at different locations and times.  Micromass 
seeding was aimed to produce such a gradient of differentiation as cells were seeded in 
the core of the scaffolds, where they were presumed to migrate outward.  Time dependent 
and distribution studies need to be performed to examine (1) differentiation and (2) cell 
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motility in the scaffold.  To control motility, the scaffold pore sizes may be altered.  The 
framework of the 3D experiments (Chapter 4, 5) may work to analyze the effect of 
motility and differentiation.   
Micromass seeding was also designed with the aim to permit more nutrient and 
byproduct flux for the cells seeded in the scaffold.  An apparatus was designed and built 
(Appendix 1) that controls several parameters, including flux and gas exchange, for in-
vitro experimentation of 3D tissue engineered structures.  By quantifying the 
concentration of oxygen, and the distribution of such concentration throughout a 3D 
structure, the alternative seeding techniques (filtration and micromass) can be compared.  
Although high flux in-vitro systems have been studied extensively (Chapter 4), 
studying the effects of increased nutrient flux in-vivo has been elusive, particularly 
because of the difficulties present with interfacing a flux generating system, that creates 
such flux in-vivo.  Using advances in micro-fluidics, a system can be designed and built 
to create a nutrient flux that is exogenous to the animal model. The proposed system 
would incorporate small, degradable channels that pass through the 3D scaffolds. Once 
transplanted, a small outlet would be set outside the body, to allow continuous or non-
continuous flow to enter via a pump or injection. The micro-fluidic tubes would be 
permeable to the nutrients as to allow for delivery throughout the construct in-vivo.  To 
test the validity of this system, in-vitro studies would be necessary, to assess nutrient 
delivery to all regions, and in-vitro osteogenic differentiation.  As nutrient flux is a 
generally favorable condition for all tissues, such an approach can yield positive results 
through out the tissue engineering realm.   
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GJIC is a highly studied phenomenon that plays a role in most tissues and may 
have far-reaching implications in fields other than tissue engineering, such as cancer 
prevention, cancer treatment, targeted delivery to communication incompetent cells, and 
as a main component to induce homeostasis. Therefore, mechanistic studies to understand 
the roles of GJIC in various aspects of biology are necessary.  In bone, studies have 
shown that the lack of GJIC in cells inhibits the phosphorylation of Sp1 transcription 
factor, which promotes the transcription of osteocalcin.  The effects of such 
phosphorylation on cells with higher GJIC need to be elucidated.  Also, based on the 
results presented in this thesis (Chapter 4, 5), higher GJIC enhances ALP.  Thus the 
mechanistic role of GJIC in the transcription of ALP, and other bone differentiation 
indicators, need to be studied.   
Also, mechanistic studies need to be performed to understand the potential 
feedback/control mechanism of Cx43 to control the regeneration of tissue.  One proposal 
to ignite this process may be to label the cells seeded in the constructs with green 
fluorescent protein (GFP) to observe what their fate is.  This way, the interference of 
outside cells may be quantified by determining what cells are embedded in mineral.   
The studies with connexin 43 can be extended to targeted delivery therapy with 
important implications.  The loss of gap junction mediated cell to cell communication not 
only leads to compromised development in many tissues and organs, but also facilitates 
tumorigenesis and autonomous cell behavior in cancerous cells.  Enabling delivery of 
connexin 43 to cancerous cells may help eliminate the autonomous behavior that 
characterizes them, which is caused by a lack of intercellular communication.  
Furthermore, low GJIC is an early sign of potentially cancerous cells.  Based on this data, 
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a novel assay based on Cx43 expression could be generated to provide patients with high 
cancer susceptibility an opportunity to detect a problematic site, and treat it at the early 
stages. 
Although transduction with a lentivirus provided to be an effective means of 
enhancing GJIC, identification, examination and production of a pharmacological agent 
that enhances the expression of Cx43 in cells may yield a powerful tool to tackle health 
related problems that are caused by compromised cell-to-cell communication.  Of the 
potential health hazards that are may be caused by low GJIC, two are at the top of the list 
of illnesses that claim lives in the United States; namely, heart disease and cancer.  As 
with any drug, the specificity, safety and, efficacy would have to be assessed in animal 
models and human trails, before it is employed.     
Combined with the work performed in this thesis, experiments elucidating the 
mechanistic role, pharmacological intervention, and eventual application of connexin 43 
to human stem cells will strengthen the understanding and application of GJIC in tissue 






















FloCulture Perfusion System 
 












The PerfuSys FloCulture Perfusion System is a perfusion system specially designed for 
bone cell cultures. The perfusion system consists of a chamber, pump, and tubing and is 
designed to provide a laminar flow of media across a cell plate at different, user 
controlled flow rates. To ensure laminar flow, low flow rates must be used. Media 
circulates through perfusion system continuously to facilitate transport of nutrients and 
waste without the need to constantly change the media. Once the perfusion system is set 
up and turned on, it can run continuously for up to 24 hours. 
 
The PerfuSys FloCulture Perfusion System is an excellent tool for users who want to test 
cell growth and survival under different test conditions, while being confident that all 





NOTES ON SAFETY 
 
The warning signs and icons shown and explained on this page are intended to assist you 
in using the product correctly and safely to prevent harm to you, others, and the system. 
• The  icon indicates something that is mandatory. 
• The  caution icon indicates matters in which bodily harm or material damage to the 
product or local environment could occur as a result of incorrect handling. 
• The  icon indicates extra information.   
 
 CAUTION: 
• AVOID DIRECT CONTACT WITH THE CELLS AND MEDIA.  Cells can carry 
diseases that are harmful to humans.   
• Dispose of materials correctly and sterilize equipment thoroughly between each 
experiment to prevent the spread of disease. 
• Use materials that are biocompatible and non-toxic when replacing parts that come in 
contact with the cells or media. 
• Follow sterilization protocols in this user manual 





Figure 1. LAYOUT DIAGRAM 
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QUICK REFERENCE GUIDE 
 
1. Prepare the cells by seeding the cells on a sterile cell plate, submerging the cell plate 
in a container of media, and placing the container in the incubator for 48 hours to 
allow the cells to adhere to the plate and begin growing. 
2. Sterilize all the components of the perfusion system (chamber, tubing, pump, and 
reservoir, if applicable), except the cell plate.   
a. Autoclave the bottom part of the chamber (Teflon part), all tubing (PharMed® 
and Silicone), the o-ring, and the 6 thumb screws.   
b. Use a 70% ethanol solution for the pump and top of chamber. 
i. Pump- Spray with ethanol before assembling system 
ii. Top of chamber- Submerge in 70% ethanol for 1 minute, remove and 
let dry under chemical hood.  
3. Assemble perfusion system under chemical hood. 
a. PharMed® tubing runs through the pump and connects to the chamber inlet 
and silicone tubing. 
b. Silicone tubing connects to the outlet of the chamber and the PharMed® 
tubing.   
4. Insert the plate and sponge (if desired) securely into the chamber.  This may be done 
by hand (with sterile gloves on) or using sterile forceps (spray both gloves and 
forceps with 70% ethanol before use).   
5. Prime the perfusion system with media: 
a. Fill chamber with media (pour from media bottle or use a 25 ml pipette). 
b. Turn pump on until bubbles stop coming out of tubing. 
c. Turn pump off. 
6. Secure the lid onto the chamber with thumb screws and check for leaks. 
7. Move the perfusion system into the incubator.  
8. Make sure the incubator is set to proper temperature and carbon dioxide levels.   
9. Plug the pump into a socket in the incubator. 
10. Set the peristaltic pump to desired flow rate level (1-4 ml/min) and turn it on.   
11. Check again that there are no leaks. 
12. Close the incubator and allow the system to run for the desired period of time. 
13. Turn off the peristaltic pump and move the perfusion system to the chemical hood.   
14. Take out a media sample and the cell plate to use for further testing. 
15. Disassemble and clean the perfusion system.  Sterilize all components before doing 














































The perfusion system can be modified to increase the scope of experiments that it is 
useful for: 
 
1. HIGHER FLOW RATES: The chamber has been designed and validated to have 
laminar flow at pump speeds of 1-4 ml/min.  Faster pump speeds and/or larger tubing 
can also be used to get higher flow rates.  In order to employ larger tubing, new tubing 
connectors of desired diameter must be substituted for the current 1/16” diameter 
tubing connectors.  The connectors can be screwed in, and Teflon tape can be used to 
secure the connectors if necessary.  Note: It is not guaranteed that at flow rates faster 
than 1-4 ml/min, the flow profile will be laminar.  Also, the tubing connectors should 
not be changed often, because this can lead to deterioration of the Teflon threading. 
 
2. RESERVOIR: The perfusion system has been designed for easy incorporation of a 
reservoir.  The reservoir should have two openings that the inlet and outlet tubing can 
pass through.  The openings must be sealed to the outer diameter of the tubing to 
ensure that the system is closed and there are no leaks.  The addition of a reservoir will 
allow the user to take pH measurements of the media, provided that another opening in 
the reservoir accommodates a pH meter. 
 
3. LID SCREWS: The threads of the screw holes used to secure the lid on the chamber 
may deteriorate over time.  If this occurs, holes can be drilled through the lid and the 
top of the chamber walls at new locations around the top of the chamber to extend the 
life of the product. 
 
4. ADDITIONAL CELL PLATES: The Chemistry Instrument Shop has the pattern for 
the cell plates, so more cell plates can be cut quickly, as needed.  The cell plates were 






Problem Cause Correction 
No flow/Pump not working No power to pump Plug in pump power cord 
No flow/Pump not working No power to pump Check to make sure that the outlet has electricity 
No flow Tubing not connected properly 
Turn off pump and connect 
tubing correctly 
No flow Tubing clogged Turn off pump, clean and sterilize tubing, re-connect 
Leak Components not connected properly 
Turn off pump and connect 
all components securely.  
Use plastic pull-ties to 
secure tubing if necessary. 
Leak Lid is loose 
Press o-ring completely into 
groove, slide lid onto top of 
chamber walls, tighten all 
screws 
Leak Component failure 
Check all components for 
deterioration.  Replace or 
fix cracked parts or tubing 
that has cuts or holes in it. 
Bubbles Did not prime system correctly 
Use thin tool to remove 
bubbles and/or re-prime 
system 
Bubbles Leak in system See above corrections for leaks 
Cell plate stuck in chamber Too tight or sticky 
Try again with a different 
tool or wait for chamber to 
cool down and try again 
Components become 
disconnected when moving 
from hood to incubator 
 
Disconnect system 
components and sterilize 
then reconnect system 
Components become 
disconnected when moving 
from incubator to hood 
 
Place under hood 
immediately.  Clean any 
spills.  Continue experiment 
as normal unless notable 
contamination has 
occurred. 
 If the sterility of the system is ever seriously jeopardized as a result of a leak or 
component disconnection, the experiment must be started over with new cells, fresh 




1. Do not drop the chamber or pump.   
 
2. Be gentle with the chamber to avoid damaging the connections with the metal 
tubing connectors.  Never hold the chamber by the metal tubing connectors. 
 
3. Avoid unscrewing the metal tubing connectors, because you could damage the 
threading.   
 Note: These end pieces may be unscrewed occasionally if tubing of a different 
diameter is desired.  Teflon tape can be used to seal them.  (See Additional 
Features.) 
 
4. If there is any physical damage to the chamber, take it to the machine shop for 
repair. 
 
5. Do not autoclave the chamber for too long or at higher pressures, because you 
could damage the interface between the Teflon and the metal. 
 
6. Always dry all components thoroughly before storage to prevent corrosion and 
bacterial growth. 
 
7. Do not over-tighten screws for top of chamber. 
 
8. Do not completely tighten one screw at a time.  Tighten all evenly by tightening 
them all small amounts alternately until all are tight. 
 
9. DO NOT AUTOCLAVE THE TOP OF THE CHAMBER 
 
10. Do not autoclave the pump.   
 





Flow range (with 1/16” tubing):  0 to 8.1 ml/min 
Accuracy at settings 0-50:   Flow: ±7% 
Power source:     AC adapter 
Chamber dimensions (base with lid): Outer: 10.54 cm (l) x 6.54 cm (w) x 5.5 cm 
(h)    (length is ??? cm with tubing 
connectors) 
      Inner: 8 cm (l) x 4 cm (w) x 4 cm (h) 
Flow duration:    Up to 24 hours 
PharMed® tubing life in pump:  1000+ hours 
Perfusion system storage temperature: -100° F to 180° F  
 
PARTS 
Item Part # Quantity Name Material Source 




2 SCT-063-25 1 (10 ft roll) Outlet tubing Silicone Tube Small Parts 
Inc. 




















7 ORS-151 1 O-Ring Silicone Small Parts  
8 8560K241 1 (11 3/4 Sq. 
In. of 3/8") 
Top Acrylic Sheet McMaster-
Carr 














11 3330 1 Material for 
Cell Plates  









































To order additional cell plates or have the chamber repaired: 
 
Kim Firestone, Instrument Maker II 
The University of Michigan Chemistry Instrument Shop 
Room A509 Chemistry Building 
930 North University Avenue 
Ann Arbor, MI 48109-1055 
Phone: (734) 764-7363 














A2. ALP activity assay (24 well plate) 
Ricardo Rossello and David H. Kohn 
  
Solutions 
a. Hank’s balanced solution (or EBSS+ solution) 
b. Harvest buffer 
- 10 mM Tris-HCl, pH=7.4 
- 0.2% Igepal (CA-630) 
- Add PMSF to the final concentration 2 mM freshly {make 200mM PMSF (0,3484g/10ml 
EtOH  aliquot to 1ml each) and add 1/100 of the total volume} 
c. Assay buffer 
- 100 mM glycine (3.785g/500ml) 
- 1 mM MgCl2,  47.61mg/500ml 
- pH=10.5 
d. PNPP: 50 mM of p-nitrophenylphosphate 
e. Stop solution: 0.1N NaOH  
Procedure 
1. Wash cells twice with 1ml of Hank’s solution 
2. Harvest cells in 400ul (2 times x 200ul) of the harvest buffer into 1.5ml 
eppendorf tube on ice 
3. [optional step] Keep the tube at -80oC (or -20oC) for storage 
4. Homogenize at low power (7-8 level, 3 times x 10sec)  (sonicator in Dr. 
Francheski’s lab)  
- Keep the tube on ice before and after the homogenization 
- Keep the tube on a beaker (ice + ethanol) during the homogenization so that the 
sample is not overheated by the sonicator tip 
5. Centrifuge the homogenized sample at 12,500 rpm for 10 min (Set the centrifuge 
at 4oC in advance) 
6. Mix the following components in a new eppendorf tube placed in 37oC water 
bath 
- 250ul assay buffer 
- 140ul harvest buffer 
- 100ul PnPP  
- 10ul sample (set the timer from this moment to measure exactly 15 min); for 




7. Put 500ul 0.1N NaOH (stop solution); for example, put this stop solution every 
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30 seconds so that every tube are on reaction for exact 15 min 
8. Read them at A405nm in the spectrophotometer (Dr. Taichiman(?)’s lab, # …….) 
 

















A3. Cell Counting with Hemocytometer  
Ricardo Rossello and David H. Kohn 
 
 
I. Equipment and Supplies 
 
Chemicals:  70% Ethanol (bottle for instruments & spray bottle) 
  Ice 
  PBS (1X) 
  Hanks Balanced Salt Solution (HBBS, Gibco/BRL #14170-120) 
  Fetal bovine serum (Gibco/BRL # 16000-044) 
Alfa-MEM ( Gibco/BRL Cat. #12571-063 –alfa-MEM, 1X) 
Media  
Note: All media preparation and other cell culture work must be 
performed in a laminar flow hood. Use a Steril 500ml Nalgene filter to 
prepare the media.  
 
For 500 ml 
50ml Fetal calf serum  




  Plastic Vials 
Flasks (Nalge Nunc Int #136196 – polysterene sterilized filter cap flask, 
angled neck, 50 ml, 25 cm(2) culture area 
  Kim-wipes 
  Paper towels 
  Nalgene Filter  
  Plastic bags 
 
Equipment  Laminar-flow hood + suction system (tube/large liquid waste flask) 
  Test tube rack (for 1.5ml tubes) 
  Microscope 
  Filtration Device  





II. Procedures:  
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1. Trypsinize cells (use Tripsinizing Celsl protocol) 
a. Check flask after initial trypsinization and retrieval of cells to observe the 
quantity of non trypsinized cells. 
b. If significant, repeat trip protocol. 
c. Trypsinize several times in order to retrieve an optimal amount of cells.   
 
2. Prepare A Pellet from Cell Suspension 
Note: This is done several times to retrieve fats when culturing cells.  
a. Place the Cell suspension 15 ml falcon tubes and centrifuge. 
i. Centrifuge at about 1000 RPM fro about 3 mins.  
b. Retreive the supernatant and decant. 
c. Re suspend with media again. 




3. Cover the Hemacytometer with Slide (see fig 1) 
 
 
4. Prepare a Cell suspension of known volume. 
a. Re suspend the pellet in a known volume (e.g. 1ml of solution).  Let sit for 
3mins.  
i. Usually you want to count such that you have about 100 cells in 
each of the compartments (fig 2). Thus, determine the volume 
based on the expected number of cells you think you will have. 
(e.g. if you think you will have 7million cells, then use about 7ml 
volume).   Note that for a number significantly more than 100, you 
should re-suspend accordingly, because the measurement is less 
accurate 
b. Take 10µL of the suspension and pipette it gently into one of the sides (fig 
1) of the Hemacytometer and 10 more for the other slide. 
 
5. Count the cells that in compartments A, B, C, and D.  
a. Take an average of these counts 
b. The number you get in a, multiply it by 104 cells 
c. Finally, multiply that number by your fixed volume, and you will have the 



















Figure 2:  Counting Chambers:  Count the number of cells in each of the chambers under 
the microscope and take the average of them.   
Number of Cells = [
4
DCBA +++ ][104 cells/ml][fixed volume] 
























A4. Cell Proliferation by Flow Cytometry (BrdU and PI)  
Ricardo Rossello and UM FLOW CYTOMETRY CORE 
 
This method, modified from Hoy CA, et.al, is applied to adherent cell cultures. It may 
also work with suspension cultures, with modifications germane to their culture 
conditions.  
Notes:  
 • An ideal sample is 1-2 x10
6 
cells. Keep all samples to about the same number of 
cells to avoid artifacts associated with cell concentration changes.  
 • Flow cytometry setup controls needed:  
 
 1) Cells stained with PI alone.  
 2) Cells with no BrdU pulse, and only the antibodies added.  
 
 • Amount of BrdU added may vary according to cell type, and proliferative potential.  
 • BrdU is light sensitive and should be added in the dark.  
 • Cells pulsed with BrdU may be photosensitive -- incubations should be in the dark 
as well.  
 
Reagents (Product code)  
BrdU (5-bromo-deoxyuridine) -- Sigma (B-5002)  
RNAse A (from bovine pancreas) -- Boehringer Mannheim (109-169)  
Tween 20 -- Fisher Biotech (BP337-500)  
Triton X-100 -- Sigma (X-100)  





-free Delbecco’s PBS  
HPLC-grade H2O  
Fetal calf Serum (FCS)  
Internal standard (IS, trout erythrocyte nuclei) – BioSure (1008)  
Antibodies  
Purified Mouse-anti-BrdU - Pharmingen (33281A)  
Goat-anti-Mouse IgG (Whole molecule) FITC conjugate - Sigma (F0257)  
Solutions  
 0.5 mg/ml RNAse A in PBS  
 
PTS -- PBS with 0.5 % Tween 20 and 5 % FCS  
HCl-Triton -- 0.1 N HCl containing 0.7 % Triton X-100  
  
 1. At desired time point(s), incubate cells with 30 µM BrdU for 15 min.  
 2. Remove BrdU media. Rinse 1x with PBS.  
 3. Detach cells -- as appropriate; trypsin, EDTA, etc. – and resuspend in 10 ml media.  
 4. Permeabilize cells:  
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Determine cell count. Aliquot desired number of cells per test sample to 15 ml 
conical tubes. Pellet at 1200 rpm for 5 min at 4
o
C. Decant supernatant, wash with 
3 ml PBS, and re-pellet. Resuspend pellet in 0.3 ml PBS, agitate gently, then add 
0.7ml ice-cold 100 % EtOH slowly. Mix gently with a 1 ml glass transfer pipette. 
The cell concentration following permeabilization should be approximately 10
6 
cells/sample. Samples can be stored in EtOH for up to 2 weeks at 4
o
C.  




cells. Mix gently with a 1 ml 
glass transfer pipette. Pellet at 1100 rpm for 8 min at 4
o
C. Decant supernatant, wash 
with 5 ml PBS, re-pellet and decant supernatant.  
 6. Add 1 ml PBS containing 0.5 mg/ml RNAse A. Agitate tube gently. Incubate at 
37
o
C for 30 min. Add 5 ml PBS, pellet at 1100 rpm, 8 min at 4
o
C. Decant supernatant.  
 7. Agitate pellet, then resuspend with 1 ml of HCl-Triton solution. Vortex gently. 
Incubate on ice for 10 min. Add 5 ml PBS, pellet at 1100 rpm for 8 min at 4
o
C. 
Decant supernatant and blot gently to dry.  
 8. Add 1 ml sterile HPLC water, vortex gently. Incubate at 97
o
C for 15 min. Note: be 
sure to cap tubes loosely to allow for expansion, and keep lid on water bath to control 
heat range.  
 9. Immediately chill in ice-water bath for 15 min. Add 5 ml PBS containing 0.5 % 
Tween 20. Pellet at 1100 rpm, 8 min at 4
o
C. Decant supernatant.  
 10. Add 100 µl PBT. Agitate gently with transfer pipette. Transfer sample to a 1.5 ml 
microcentrifuge tube.  
 11. Add 100 µl of a 1:100 dilution of anti-BrdU Ab. Incubate at RT for 30 min. Add 
1.2 ml PBT. Pellet at 3200 rpm for 2 min in a microcentrifuge (Eppendorf Centrifuge 
5415 C). Decant supernatant. Note: Speed and time are IMPORTANT -- at this point, 
the pellet is very loose and it may be necessary to re-pellet.  
 12. Add 150 µl of a 1:20 dilution of FITC-conjugate Ab. Incubate at RT for 30 min. 
Add 1.2 ml PBT. Pellet at 3200 rpm for 2 min in a microcentrifuge.  
 13. Resuspend pellet in 0.5 ml PI stock solution. Transfer sample to a 0.5 ml snap-top 
microcentrifuge tube. Cover samples with foil.  
 14. Leave samples at RT for 1 hr before taking them to the Flow Lab.  
 
A5. Designing a Filtration Device for Scaffolds 
Ricardo Rossello 
 
A filtration device has proven to increase the cell retention in porous PLGA and 
Mineralized PLGA scaffolds significantly [Appendix 1].  The basic principle is to have 
cell suspension filter through tightly packed scaffolds, in order to (1) create a gradient so 
that cells can pack the scaffold, and (2) those cells that filter through will have other 
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opportunities to attach as the suspension cycles. The basic components of the apparatus 
(figure 1) are: 
 
1. Peristaltic Pump 
2. Tubes  
3. Chamber 
 
There are other components that may become essential based on the experiment, such as 
a reservoir of media.  Although these three components are simple in essence, they need 
to be tailored to the particular experiment. I will discuss the design criterion needed to 
adjust the apparatus for any particular experiment.  
 
Figure 1:  Basic Schematic of a filtration device to seed cells into Scaffolds.  
 
 




When designing the filtration experiments the first order of business is determining the 
dimensions of the scaffold (Diameter, Thickness, mm3).  This is very important because 
based on these all other parameters have to be determined.  Scaffold Diameter will drive 





the diameter of both the chamber and tubes.  Scaffold thickness will determine how many 
scaffolds you can use to get an even cell profile.   
 
Other important parameters are the flow rate, inner diameter and length of the tubes.  
These have to be determined based on the flow profile (laminar vs. turbulent; RE see next 
section), and desired stress component.  Fluid dynamic equations that should be used to 
determine these parameters are in Appendix 2. 
 
Fluid Dynamics 
Tests have been conducted to determine which type of flow causes the best cell 
proliferation, and of turbulent flow, laminar flow, and no flow, laminar flow causes the 
greatest amount of cellular growth. [1] Turbulent flow causes stagnant points and 
dramatic shear stress variations, which may kill cells or tear them from the plate’s surface.  
Laminar flow is a steady flow in which a velocity gradient is present that extends from 
the fastest velocity at the center of the flow to zero flow at the wall or stationary object.  
Laminar flow occurs when viscous forces dominate in the flow.  This is determined by 
the Reynolds number which is a non-dimensional number takes into account the 
parameters of the flow.  If the Reynolds number is less than 2300, the flow is laminar.  If 
the Reynolds number is greater than 2300, the flow is not laminar.   
 
When fluid flow undergoes a change in diameter there is a region in which turbulent 
flow can occur for a limited distance.  This turbulent region is called the entrance region.  
This entrance region can be calculated from the Reynolds number and the diameter of the 
new region of flow. This distance begins at the point where the radius of the cross 




Physiological conditions are not the only factors that affect cell growth.  Contamination 
from bacteria can easily occur in cell culture systems if special care is not taken to keep 
the system sterile.  Providing an environment that cells find ideal to live and reproduce in 
means that other organisms, such as bacteria, find this environment favorable too.  Just 
one component being contaminated can lead to bacterium infecting the system and  
ruining an entire experiment by killing other cells or creating byproducts that can alter 
experimental results.  Bacteria multiply and grow very quickly, which is why it is 
extremely important to make sure that every component in the system is completely 




PharMed® tubing and silicone tubing were used in our perfusion system.  Silicone tubing 
was used to connect the outlet of the chamber to the inlet of the reservoir and was 
selected because it is an industry standard for cell culture tubing.  Silicone tubing is 
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permeable to gas, which allows CO2 exchange in the incubator.  This allows the pH of the 
media to be controlled.  PharMed® tubing was used to connect the reservoir outlet to the 
entrance of the chamber.  The reason for using two different types of tubing in our system 
design is durability.  When using Silicone tubing for peristaltic pumps, it has a 75 
hour operating life before failure, which means it would have to be changed often 
(based on the 6hour optimal time period, every 12 runs or so, Appendix 1).  On the other 
hand, Pharmed® tubing’s operating life before failure is over 1000 hours, so it lasts a 
long time in the pump.  However, PharMed® does not meet an acceptable gas 
permeability requirement, so the Silicone tubing is needed for part of the system to allow 
for the necessary gas exchange.    Figure 9 shows the gas permeability coefficient of the 
two types of tubing for various gases.  Tube specs and info in appendix 3.  
 
Permeability Coefficient Comparison  
 
 
Figure 9: The permeability of carbon dioxide is over 25 times larger in  




The peristaltic pump is the research standard for cell culture perfusion systems.  The 
main reason for this is that there is no contact between the media and the pump.  This 
eliminates the pump from being a possible contaminant to the cells being cultured.  The 
peristaltic pump also provides a constant flow at variable flow rates.  Our lab  
purchased the PTP-2408 (drawer labeled peristaltic pump in 2228) from Small Parts, 
Inc (please note that based on your requirements, you may need a different peristaltic 
pump) .  It has a pump speed of 1.5-26 RPM and allows for flow rates from 0.3 to 90 






The design of the chamber is the primary concern in designing the system.  The chamber 
must be designed such that there is laminar flow trough the scaffolds.  Sheer stress and 
uniformity of flow are variables to take into account which can affect a biological 
outcome.  The chamber must also be biocompatible and sterilizable.  There is no specific 
upper constraint on size except that it fit in the incubator, but the larger the chamber, the 
more media will be required and the larger the scaffold may have to be (this should not 
be a concern for our scaffolds are small) .  
 
For scaffolds, the chamber will be a cylindrical non-stick glass tube that will be 
sterelizable [these glass vials are sold on fisher, pending the size].   Typically this tube is 
the same one used for casting the scaffolds.  A chamber can also be made from Teflon, if 
a particular size is desired.  The tradeoff is the observational capabilities of glass, versus 
the ability to have a machined chamber with the specific size that is desired.  Other 
options are acceptable so long as they follow the basic criterion that the chamber needed 
be biocompatible, sterilizable, and non-adhesive for cells. 
 
Inlets and outlets to the chamber can be machined if such a difference in cross sectional 
areas is desired.  However, for most cases, matching the inner diameter of the tubes to the 
outer diameter of the chamber and placing a robber stopper over it will work.  Figure 2 





Figure 2:  Flowchart  
















Assembly of System and Priming  
After sterilizing all of the components, the user will have to assemble the perfusion 
system.  The perfusion system should be assembled under a hood to prevent any 
contamination during assembly.  The basic setup, however, is as follows.  The pump is 
connected to the chamber entrance and reservoir by PharMed® tubing.   Silicone tubing 
is used to connect the exit of the chamber to the reservoir.   
 
Filling the perfusion system with cell suspension, securing the inlet and outlet stoppers, 
and checking for leaks are the next steps.  Working under the chemical hood, prime 
suspension into the system (and reservoir if necessary) until the chamber, reservoir, and 
tubing are full, and without air bubbles.  Priming can be done in a variety of ways, 
pending on the size of the tubes and such.  I poured as much of the suspension as possible, 
and then filled the remaining spaces with a syringe.  After checking for leaks and 
ensuring there are none, you can then carefully move the perfusion system into the 
incubator.  The incubator has a rubber stopper in the back end, which will be necessary to 




Once in the incubator, you need to prepare the system for the experiment.  Secure the 
chamber in the incubator to ensure that it will not move during experiment and connect 
the AC outlet.  After the chamber is secured, once again check for leaks and make sure 
everything is connected properly.  Check that the incubator is set to proper temperature 
and carbon dioxide levels.  Then set the peristaltic pump to desired flow rate level (1-
4ml/min).   
 
After making sure everything is set up properly, the user is ready to run the experiment.   
First, turn on the peristaltic pump and look to make sure media is flowing through the 
system.  Next, check once again that there are no leaks.  Finally, close the incubator and 
allow the system to run for the desired period of time. 
 
Once the desired experimental run time is complete the user can open the incubator and 
turn off the peristaltic pump.  Next, move the perfusion system from the incubator to the 
chemical hood.  The user can then take out the plate and media from the reservoir and 
save them for further testing.   
 
Finally, the last step is to disassemble and sterilize the system again.  Empty the 
remaining media-suspension from the system into a jar with bleach.  Decant the bleach-
suspension solution into a sink approved for biological disposal (Culture room).  Then the 
system can be taken apart and sterilized with appropriate sterilization protocols (pending 










Preliminary filtration data 
 
Adhered Cell Count (Ricardo Rosselló) 
 
Filtration seeding had a significantly higher percentage of cells adhered, than the 
dynamic or static seeding (figure 4).  Filtration seems to have reached carrying capacity 
at the 6 hour period (92.32+/6.12), while the other two methods show a steady increase in 
attached cells. Mineralized scaffolds showed no significant difference to the PLGA only 
scaffolds.  However, as time increased, the p-values decreased. For the filtered seeded 






Figure 4:  The number of cells was accounted for after each time period, and for each method.  
The scaffolds where washed to remove the free cells trapped in the construct.  The remaining 
cells were trypzinied and accounted for.  There is a significant difference (p<0.001) at all time 
points between seeding techniques.  There is also a significant difference between the 1hour and 
6hour mark in the filtration process (p=0.034).  Another interesting result to note is that there is 
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a much smaller variation is observed at all points in the filtration process than in the highly 


















The following formulas were used for deriving the flow dynamics within the chamber. 
 
 
The effective diameter for an arbitrary shape is De: 
 
 
The velocity of the fluid is: 
 
The Reynolds Number is given by: 
 
The entrance length is: 
 
 
The pressure differential is give by: 
 




A6. Protocol for Extracting Bone Marrow Stromal Cells from Rat Femur and 
Tibiae  
Ricardo Rossello and David H. Kohn 
 
I. Equipment and Supplies 
 
Chemicals:  70% Ethanol (bottle for instruments & spray bottle) 
  PBS (1X) 
  Hanks Balanced Salt Solution (HBBS, Gibco/BRL #14170-120) 
Media  
Note: All media preparation and other cell culture work must be 
performed in a laminar flow hood. Use a Steril 500ml Nalgene filter to 
prepare the media.  
 
For 500 ml 
50ml Fetal calf serum  




  Glass (Pasteur) pipettes + canister (sterile) 
  Pipette tips 
  Petri Dishes 
  3.0 ml Syringe  
  1.5 ml tubes 
Flasks (Nalge Nunc Int #136196 – polysterene sterilized filter cap flask, 
angled neck, 50 ml, 25 cm(2) culture area 
  Kim-wipes 
  Nalgene Filter  
  Sharpie marker  
 
Equipment  Laminar-flow hood  
  Tweezers, forceps (sterile + keep in EtOH under hood) 
  Microscope 
  Markers 
  Vortexer  
  Hemacytometer  
 
General Procedural Notes 
 
• Rinse gloves w/EtOH every time one re-enters hood 
• Clean the hood with EtOH before and after the procedure. 
• Autoclave dissection instruments before hand 
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• All culture vessels, test tubes, pipet tip boxes, stocks of sterile eppendorfs, etc. 




1. Set up 
a. Place the petri-dish containing the bones inside the hood. 
b. Set up 3 additional petri dishes 
i. Media 
ii. Bone remains 
iii. BMSC 
c. Place about 15 ml of media to the media petri dish.  Use extreme caution 
when using the syringe; only touch the part necessary for suction.   
 
 
2. Retrieval of BMSC 
a. With forceps, use a clipper to break the outer extremeties of the bones 
i. A cut should be done at or close to where the bone marrow can be 
seen. 
b. Retrieve 3ml of media with the syringe. Use the syringe to flush out the 
bone morrow out of the bone, and into the BMSC plate.   
c. Use the same media decanted from the bone, to further flush morrow cells. 
This time flush the cells through the other side of the bone.  Do this 
procedure about 4 times. 
d. Perform a-c for all of the bones 
e. See if there is any marrow left in the small peaces of the bone, so that you 
could retrieve that too. 
 
3. Re-suspend the morrow cells 
a. Use the syringe to re-suspend the BMSC 
 
4. Observation and storage 
a. Mark the date and strain of rat used  
b. Count the cells with a Hemacytometer (see Cell Counting with 
Hemacytometer Protocol ) 
c. Place cells in a CO2 incubator  
 
5. Further observation 
a. Observe and monitor the cells every two days. 
b. Change media every 2-3 days. 
c. Passage the cell, as specified in the tripsinizing and sub culturing cells 
protocol, in 7-10 days. 
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A7. Filtration Seeding of Scaffolds 
Ricardo Rossello and David H. Kohn 
 
 
I. Equipment and Supplies 
 
Chemicals:  70% Ethanol (bottle for instruments & spray bottle) 
  Ice 
  PBS (1X) 
  Hanks Balanced Salt Solution (HBBS, Gibco/BRL #14170-120) 
  Fetal bovine serum (Gibco/BRL # 16000-044) 
Alfa-MEM ( Gibco/BRL Cat. #12571-063 –alfa-MEM, 1X) 
Media  
Note: All media preparation and other cell culture work must be performed in a laminar 
flow hood. Use a Steril 500ml Nalgene filter to prepare the media.  
 
For 500 ml 
50ml Fetal calf serum  




  24 well vials   
  Plastic Vials 
Flasks (Nalge Nunc Int #136196 – polysterene sterilized filter cap flask, angled neck, 50 
ml, 25 cm(2) culture area 
  Kim-wipes 
  Paper towels 
  Nalgene Filter  
  Plastic bags 
 
Equipment  Laminar-flow hood + suction system (tube/large liquid waste flask) 
  Tweezers, forceps (sterile + keep in EtOH under hood) 
  Test tube rack  
  Microscope 
  Incubator (CO2)  
  Filtration Device  
 
General Procedural Notes 
Autoclave Filtration Materials  before usage. 
 




Trypsinize cells (see Trypsinizing Cells) 
Observe flasks after trypsinization, if there appears to be a large number of cells on the 
flask after trypsinization, repeat the procedure again.  
Pipette media into the flask to stop tripsinizing effects. Use this media a few times to 
wash of some cells, by tilting the flask to the side (fig 2) and repidetely washing. 
 
 
Device Setup (fig 1) 
Connect tubes to the pump.  
Place wetted scaffold (see Wetting of Scaffolds) on to the sterilized crystal tube. Utilize 
the sterilized tweezers to place it. 
Insert cell suspension into to the tubes. Make sure it is saturated with the desired cell 
suspension density (see Cell Count Protocol).  
Close filtration loop 
 
 
3. Place Filtration Device into CO2 Tank 
Connect the Device to the adaptor (at the far end of the incubator) 
Turn on the pump. 
 
 
NOTE: For Maximum Cell Count – Switch off direction of flow periodically , to 
maximize seeding and adhesion. 
 
 
Retrieve scaffolds from the apparatus  
Take the tubes out of the apparatus. 
Carefully detach the tubes in the hood, over a Petri dish. 
Utilize tweezers to take scaffold out. 
Place scaffold in Petri dish or 24 well plates.  To ensure hydration of the scaffold, wet the 
scaffold by pipetting a small amount of media to the scaffold. Make sure the scaffold 
stays hydrated.  For example:  for a 4mm diameter and 1 mm thick scaffold, pipette 
about 12µL of media. 



















     Pump  
Fig 1:  Filtration apparatus:    
a) the arrows signify the tubes 
that where the flow occurs 
b) This is the crystal tube 
where the scaffold is placed 
c) Scaffold 
d) Variable pump system 
a. Contains velocity 
control and 




  1 
1. Tilt the flask slightly, such that 
the media and cell suspension are 
in the bottom corner 
2. Pipette over the whole surface a 
few times to recover more cells 
2 
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[Purpose] Gelform is the usual hemostatic sponge in dental clinic, which consists of 
absorbable gelatiin. To have the in vivo study of MSCs, we cast Gelform blocks as 





  Xylacine 
Saline 
 
Consumables:  Sterile Gelfoam sponge. 12 sq cm× 7 mm 
Sterile gauze 
Serum-free alpha-MEM serum 
6-well culture plate 
 
Equipment:  Laminar Flow Hood 






1. Under sterile environment, place the Gelform sponge onto a 100mm Petri-Dish. Slice 
the sponge horizontally in half with the scalpel (3.5  mm height each). Use scissors to 
cut the Gelform into 3.5 mm cubes, place the Gelform cubes onto a pre-wet gauze (by 
alpha-MEM), press with dry gauze to drive off the air bubbles. Then dry Gelform 
with another dry gauze.  
2. Cells were harvested and counted, then alliquote into ependorf tubes at 2-3 
million/ml/tube. Centrifuge and aspirate the supernatant, reserve 30-50 µl medium 
and suspend cell pellet by pipetting.  
3. Place one sponge/tube and incorporate cells suspension into it by gently dipping 
sponge to the bottom of the tube. Co-culture the cell-sponge at 37˚C in an incubator 
for 30 minutes. 
4. Take tubes and surgical instruments to Room 6203 ( SCID room). Anesthesize mice 
(figure 1) with intraperitoneal ketamine cocktail.  
 
Ketamine cocktail: 
0.3 ml Ketamine 
0.2 ml Xylacine 
0.5 ml Saline 
Dosage: 50- 100 µl /mouse 
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5. Make two small vertical incisions (1 cm-long) on the back along the spine. One 
incision at hindlimbs level and the second one at forelimbs level. 
6. Make bilateral subcutaneous pouches by dissecting the skin with blunt scissors. Place 
one sponge in each" quadrant" of the animal's back. Total: 4 sponges/animal. 
7. Suture the incision to close wounds (figure 2). 
8. Monitor mice recovery until the next day.  




Figure 1:  Inject mice by grabbing the skin over the cervix and  










A9. Cell Seeding by Micromass 




I. Equipment and Supplies 
 
Chemicals:  70% Ethanol (bottle for instruments & spray bottle) 
  Ice 
  PBS (1X) 
Hanks Balanced Salt Solution (HBBS, Gibco/BRL #14170-120) 
  Fetal bovine serum (Gibco/BRL # 16000-044) 
Alfa-MEM ( Gibco/BRL Cat. #12571-063 –alfa-MEM, 1X) 
Media  
Note: All media preparation and other cell culture work must be performed in a laminar 
flow hood. Use a Steril 500ml Nalgene filter to prepare the media.  
 
For 500 ml 
50ml Fetal calf serum  




  Plastic Vials 
Flasks (Nalge Nunc Int #136196 – polysterene sterilized filter cap flask, angled neck, 50 
ml, 25 cm(2) culture area 
  Kim-wipes 
  Paper towels 
  Nalgene Filter  
  Plastic bags 
 
Equipment  Laminar-flow hood + suction system (tube/large liquid waste flask) 
  Test tube rack (for 1.5ml tubes) 
  Tweezers, forceps (sterile + keep in EtOH under hood) 
  Microscope 
  Filtration Device  
  Centrifuge  
 
 
II. Procedures:  
 
Trypsinize cells (use Tripsinizing Celsl protocol) 
Check flask after initial trypsinization and retrieval of cells to observe the quantity of non 
trypsinized cells. 
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If significant, repeat trip protocol. 
Trypsinize several times in order to retrieve an optimal amount of cells.   
 
Prepare A Pellet from Cell Suspension 
Note: This is done several times to retrieve fats when culturing cells.  
Place the Cell suspension 15 ml falcon tubes and centrifuge. 
Centrifuge at about 1000 RPM fro about 3 mins.  
Retrieve the supernatant and decant. 
 
Count the cells using the Hemocytometer (see Cell Counting with Hemocytometer 
Protocol). 
 
Re suspend the cell pellet, and aliquot an, on 1.5ml tubes, the amount desired for the 
making of the macro-mass of cells you are going to seed. For example.  If you have a cell 
count of 1 Million Cells, and you want to make micro masses of 0.2 million cells, aliquot 
1/5 of the cell suspension to 5 tubes, and centrifuge them. 
 
After centrifuge, extract the supernatant (as much as you can), and leave the pellet. In 
order to do this carefully, retrieve the final micro liters of supernatant with a micropipette.   
 
Place 1.5ml tubes containing the pellet into the CO2 Incubator for 30mins-1hr.   
 
Micropipette these micro masses into the scaffolds (which are on a 24 well plate or Petri 
Dish), by placing the dense glob on the geometrically desired position.  Slightly hydrate 
with some media. Place the seeded scaffolds into the incubator for another hour. Retrieve 
the plate and hydrate the scaffolds (more than before). Place Scaffolds in incubator until 











A10. Protocol for Flow Cytometry Activated Cell Separation (FACS) 
Ricardo Rossello and UM FLOW CYTOMETRY CORE 
 
Device: 




Sterile 10-cm tissue culture dishes 
6,12,24 well plates 
cell strainers (Falcon 2235) 
Falcon Tubes 
Cell culture medium  
Trypsin/EDTA 
PBS 
Calcenin-AM stock Solution (Sigma) 
Vybrant DiI stock solution (Molecular probes) 
 
Gap Junction Competent Cell Line (e.g. BMSCs) 
 




1. Add 1µL of Calcenin stock solution to 1mL medium mix. 
2. Add 1µL  of DiI stock solution and mix again.  
3. Vary mixes accordingly to specifications 










A11. Immunohistochemistry stain on Connexin43-treated cranial defect sections 




1. Deparafinized slides.  
Xylene 10 min×2 
2. Rehydration 
100% EtOH 2×1 min 
95%   EtOH 1 min 
75%   EtOH 1 min 
3. PBS 10 min wash 
4. H2O2 5 ml (Stock 30% 20 ml + 180 ml dd H2O ---→ 3% final concentration) 
5. PBS 10 min wash 
Use a decloaker chamber, set up 2 mins (first switch over 20 min, then turn back), merge 
the slides in Antigen-retrieval reagent (1×(Biocare Medical), diluted with PBS) 
6. PBS 10 min wash 
7. Block the slide with sniper for 5 min, room temperature 
8. Primary Ab incubation ( diluted 1:1000 in Da Vinci Green antibody diluent 
(Biocare Medical)), load 100 µl on each slide 
9. Place the slides on a wet chamber overnight at 4° C. 
 
Day 2: 
10. Drain with PBS 10 min 
11. 2nd Ab incubation (Biotinylated Coat-anti-Rabbit IgG (BioCare Medical) 10-15 
min, room temperature) 
12. PBS 10 min wash 
13. Incubate for 15 minutes with streptavadin-HRP (Biocare Medical) 
14. PBS 5 min wash 
15. DAB reaction (Zymed; South San Francisco, CA, 12.5µl + 1 ml buffer all, 75 µl  
on each slide) for 30 seconds.  
16. PBS wash 5 min 
17. Stain with hemotoxylin for 30 seconds, then rinse with tapping water immediately 






A12. Westernblot Protocol and Preocedures 




    
1)  Load 20 to 25 microgram of whole cell lysate per lane in an SDS-PAGE mini gel.  
2)  Run at 20 mA per gel untill the dye front is close to the bottom.  
3)  Transfer the proteins to a nitrocellulose membrane (S&S NCTM) at 250 mA in 
transfer buffer for 1-4 h, depending on the size of the target protein.  
4)  Incubate the blot with blocking buffer (5% non-fat dry milk in TBS) overnight at 4oC 
or 2 h at room temperature (RT).  
5)  Incubate the blot with primary antibody (diluted 1:250 to 1:1000 in blocking buffer) 
for 1 h in blocking buffer at RT.  
6)  Wash the blot 3 x 10 min in washing buffer (TBS containing 0.1% Tween 20) with 
shaking.  
7)  Incubate blot with anti-rabbit IgG-HRP conjugate (Sigma) (diluted 1:10,000 - 1:2,000 
in blocking buffer) for 1 h in blocking buffer at RT.  
8)  Wash 3 x 10 min in washing buffer with shaking.  
9)  Drain washing buffer, add ECL solution (Amersham) and develop for 1 min.  














A13. Infection Protocol for Adherent Cell Types 
Ricardo Rossello, Thomas Langinan, Eddy Kizana, and David Kohn 
This protocol may be used for the infection of adherent cell lines. The use of qualified 
retroviral supernatant in custom infections is absolute. To qualify the viability of 
retroviral supernatant, use either the Titer Assay for Retrovirus protocol or the 
‘Qualification of FIV-GFP Supernatant Infection Efficiency SOP’.  
Materials 
1  6-well Tissue Culture Plate at 5.0x105 cells per well and appropriate media 
1 Disposable 9in Glass Pasteur Pipette 
3.75ml Qualified 10x retroviral supernatant 
2.5µl 4µg/ml 0.22µm Filter Sterilized Polybrene dissolved in Milli-Q 
2.5µl 4mg/ml 0.22µm Filter Sterilized Protamine Sulfate dissolved in Milli-Q 
1 5ml Pipette 
1 30ul Pipette tip 
  
Equipment 
1 Pipette Aid 
1 20µl Pipette-Manµ 
Tissue Culture Hood 
37C Incubator w/ 5% CO2 
32C Incubator w/ 5% CO2 






Prepare Cells For Infection. 
- Split target cells into a 6-well tissue culture plate at 2.5x105 and incubate 
overnight at 37C w/5.0% CO2. This will provide ~50% confluent cells the following day.  
Infection. 
- Observe cells under microscope to verify that they look healthy and are at the 
right confluence. 
- In a Tissue Culture Hood, aspirate cellular media from the first row of wells and 
aliquot 1.25ml viral supernatant as described below.  
- Once the viral supernatant is applied to the cells, aliquot the localization molecule 
into the wells as described below and gently rock the plate for even distribution of 
molecule. The final concentration of each localization molecule is 8µg/ml. 
Table 1. Aliquot the retroviral supernatant into the corresponding wells as described. The 
media plus localization molecule wells serve as controls to monitor any cell death. 
 
1.25ml 10x Sup 
2.5µl 4mg/ml Polybrene 
1.25ml 10x Sup 
2.5µl 4mg/ml Protamine 
Sulfate 
1.25ml 10x Sup 
1.25ml Media 
2.5µl 4mg/ml Polybrene 
1.25ml Media 




- Spin-inoculate the cells by placing the plate in a multi-well plate swinging bucket 
rotor and place in Eppendorf 5810R Centrifuge. Spin the plate at 2500rpm for 90m at 
30C.  
- Incubate the cells at 32C with 5%CO2 for 24-48h. 
- Replace viral supernatant with appropriate cell media and return cells to incubator. 
- Analyze trans-gene expression >72 hours post infection. In some instances, trans-




- The splitting of the cells, preparation of infection conditions, infection of target 
cells, and changing the media must be done using sterile technique in a biological safety 
cabinet to prevent contamination. 
- At any step during the infection, antibiotics may be added to the media or 
supernatant if contamination is present. 
- The starting number of cells may be varied to account for total cell availability. 
Successful transductions have been carried with as little as 2.0 x 105 cells per well. This 
does however translate into fewer total cells successfully transduced. 
- The cell death control wells may be disregarded in favor of more wells of cells to 
be transduced once the effects of the localization molecules have been noted. 
- The duration the viral supernatant is on the cells can go from overnight to 2 days. 
We have seen that a longer exposure can produce higher transduction efficiency, 
although this is proportional to increasing cell death, as VSVG and the localization 
molecules can be toxic. We usually let the 911 cells go overnight.  
- Multiple infections may be preformed on the same cells to increase the 
transduction efficiency. To do this allow the primary infection to stay on the cells 
overnight, replace the supernatant with media and allow the cells to recover for 24h and 












A14. Repair of craniotomy defects with genetically modified cells 
Ricardo Rossello, Zhuo Wang, and David Kohn 
 
All experiments were performed in accordance with the University Committee on Use 
and Care of Animals (UCUCA). Animals were housed in a light- and temperature-
controlled environment and given food and water ad libitum.  
 
Animals 
4- to 5-week-old female SCID mice (N:NIH-bg-nu-xid; Charles River Laboratories, 
Raleigh, NC, USA)  
 
Chemicals:  Ketamine 
   Xylacine 
Saline 
 
Consumables:  Sterile Gelfoam sponge. 12 sq cm× 7 mm 
Sterile gauze 
Serum-free alpha-MEM serum 
6-well culture plate 
 
Equipment:   Laminar Flow Hood 
Surgical scissors, blade (15#) and scalpel  




1.  Under sterile environment, place the Gelform sponge onto a 100mm Petri-Dish. Slice 
the sponge horizontally in half with the scalpel (3.5  mm height each). Use scissors to cut 
the Gelform into 3.5 mm cubes, place the Gelform cubes onto a pre-wet gauze (by alpha-
MEM), press with dry gauze to drive off the air bubbles. Then dry Gelform with another 
dry gauze.  
 
2. Cells were harvested and counted, then alliquote into ependorf tubes at 2-3 
million/ml/tube. Centrifuge and aspirate the supernatant, reserve 30-50 µl medium and 
suspend cell pellet by pipetting.  
 
3. Place one sponge/tube and incorporate cells suspension into it by gently dipping 
sponge to the bottom of the tube. Co-culture the cell-sponge at 37˚C in an incubator for 
30 minutes. 
 
4. Take tubes and surgical instruments to Room 6203 ( SCID room). Anesthesize mice 
(figure 1) with intraperitoneal ketamine cocktail.  
 
Ketamine cocktail: 
0.3 ml Ketamine 
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0.2 ml Xylacine 
0.5 ml Saline 
Dosage: 50- 100 µl /mouse 
 
5. A linear scalp incision was made from the nasal bone to the occiput and full-thickness 
flaps were elevated.  
 
6. The periosteum overlying the calvarial bone was completed resected. A trephine was 
used to create a 5-mm craniotomy defect centered on the sagittal sinus and the wounds 
were copiously irrigated with Hanks’ balanced salt solution (HBSS) while drilling.  
 
7. The calvarial disk was removed carefully in order to avoid injury to the underlying 
dura or brain.  
 
8. After careful hemostasis, gelatin sponges previous loaded with  cells were placed into 
the defects. The sponges filled the entire defect and attached the bone edges around the 
entire periphery. 
 
9. The incisions were closed with 4-0 Chromic Gut suture ( Ethicon/Johnson & Johnson, 
Sommerville, NJ) and the mice recovered for anesthesia on a heating pad.  
 
 
Figure 1:  Inject mice by grabbing the skin over the cervix and  







A15. Transduction of BMSCs with LV-Cx43-GFP 
Ricardo Rossello, Zhuo Wang, and David Kohn 
 
For the protocol prior to culturing, 25 ml of fresh whole bone marrow cells in a 50 ml tube will be 
transduced with 25 ml of the produced lentiviral particles in suspension in a rotation incubator at 
a MOI of 50 in Media.  Transduction will be carried out for 5 h at room temperature in the 
presence of 100 M deoxynucleoside triphosphates (Amersham Pharmacia Biotech Inc., USA) and 
protamine sulfate (8 µg/ml), or at 37°C in the presence of 8 µg/ml polybrene (Sigma, USA).  
After transduction, cells will be washed twice by centrifugation at 100 g for 12 min, followed by 
re-suspension of the cells in 1xPBS.  After 12 days of culture, the TRC3 cell product, including 
adherent and non-adherent cells, will be evaluated for GFP expression by fluorescence 
microscopy.  Quantification of the proportion of GFP cells will also be performed after a week of 
transduction.  Non-transduced BMSC will be used as negative control for GFP expression.  
 
For transduction during culture, BM MNC will be plated at a density of 22.5x106 cells per T75 
flask.  The lentiviral vector with a titer of 108 cells/ml will be used to perform a transduction at 
day 3-4 of culture when individual colony-forming units are initiated which are at a high 
proliferative status susceptible to viral transduction.  In addition, transduction will be carried out 
in the presence of 8 µg/ml of protamine sulfate that can enhance the transduction efficiency.  5 ml 
of filtered virus-containing media will be mixed with 5 ml of fresh LTBMC and 8 µg/ml 
protamine sulfate will be added to the cell cultures for approximately 16 h (infection phase), 
followed by replacing this media with fresh media for 6-8 h (recovery phase).  The cells will be 
exposed to three cycles of virus infection.  After 1,2, 4, 8, 12 days of incubation, BMSCs cells 
will be examined under fluorescent microscopy, and  will be trypsinized for FACS analysis. 
 
Controls will include non-transduced cells, cells subjected to transfection medium without viruses, 
and cells transduced with the vector minus GFP. 
 
I. Equipment and Supplies 
Chemicals:  70% Ethanol (bottle for instruments & spray bottle) 
  Ice 
  PBS (1X)  
  Hanks Balanced Salt Solution (HBBS, Gibco/BRL #14170-120) 
  Fetal bovine serum (Gibco/BRL # 16000-044) 
Alfa-MEM ( Gibco/BRL Cat. #12571-063 –alfa-MEM, 1X) 
LV-Cx43-GFP titers [frozen at 10x; Titer 106cells/ml] 
Protamine [8ug/ml] 
Media  
Note: All media preparation and other cell culture work must be 
performed in a laminar flow hood. Use a Steril 500ml Nalgene filter to 
prepare the media.  
 
For 500 ml 
50ml Fetal calf serum  
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  24 well vials   
  Plastic Vials 
Flasks (Nalge Nunc Int #136196 – polysterene sterilized filter cap flask, 
angled neck, 50 ml, 25 cm(2) culture area 
  Kim-wipes 
  Paper towels 
  Nalgene Filter  
  Plastic bags 
 
Equipment  Laminar-flow hood + suction system (tube/large liquid waste flask) 
  Tweezers, forceps (sterile + keep in EtOH under hood) 
  Test tube rack (for 1.5ml tubes) 
  Microscope 
  Incubator (CO2)  
 
 
1.  Culture cells as indicated in tissue culture protocol 
2.  Achieve 30-50% confluency before infection with virus 
3.  Unfreeze the LV titer in a water bath; heat media to 37C in the same water bath 
4.  Calculate the Titer necessary for your infection [based on Multiplicity of Infection 
(MOI)– Check MOI protocol]. 
5.  Remove all the media from the flask or well plate, and place 107-8 titer into flask or 
plate.  Immediately after, pipette 8ug/ml protamine into the flask. 1ml for each 8ml of 
media-virus suspension used.  
6.  Incubate for 16 hours for infection to occur. 
7.  After this time period, remove Media and wash with HBBS two times. 
8.  Pipette fresh cell media –as described above – to flasks for 6-8 hours. 
9.  Repeat step 7 
10 Repeat steps 8, only let media for 3-4 days.  
 
Trouble shooting:  When cells are not thriving – increasing the FBS to 15-20% is a 






A16. LVCx43GFP Plot 












A17. Calvarial Defect Model:  Enhanced GJIC regenerates more bone in a critical 
sized defect 
 
Tissue engineering can be defined as the proccess by which a functional 3D tissue is 
generated using cells, scaffolds and devices that enable cell growth, organization, and 
differentiation.{{253 Griffith,L.G. 2006;60 Vacanti,J.P. 1999; 61 Langer,R. 1993;  }}.  
Successful and complete regeneration of tissues can be achieved for certain types of 
tissue that are either thin in nature (skin), or avascularized{{263 Freed,L.E. 2002;264 
MacNeil,S. 2007;  }}. Regeneration of bone has been more challenging, since the thick 
nature of the tissue inhibits necessary transport of nutrients and cues for bone formation 
through out the 3D construct{{36 Laurencin,C. 2006; }}.   
 
Our group has shown that overexpressing the gap junction protein Cx43 in bone marrow 
stromal cells, increases intercellular communication and differentiation in 3D cultures 
over cells expressing normal levels of Cx43.  In addition, we have shown that the effects 
of a known bone osteoinductive agent, BMP7, are augmented when Cx43 is 
overexpressed.  We have also shown that Cx43 overexpression leads to greater 
distribution and more bone regeneration in an ectopic model (Chapter 4).  Our current 
study investigates the effects of GJIC in a more clinically relevant model by examinating 
the healing of a critical sized defect in the calvaria of nude mice.   
 
Materials and Methods 
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Bone marrow stromal cell (BMSCs) isolation and culture 
Five-week old C57BL/6 mice were used to isolate bone marrow cells from the femoral, 
tibial and humeral cavities (six bones per animal) as previously described11, 55. Briefly, 
the bone marrow was mixed with minimum essential medium (α-MEM; Gibco 
Laboratories, Grand Island, NY) containing 10% fetal bovine serum (FBS) (Gibco) and 
antibiotics (100 µg/ml penicillin G and 100 IU/ml streptomycin) at 37°C in 5% CO2/95% 
air). Cells were pelleted by centrifugation at 1000 rpm for 5 min at 4°C, resuspended in 
10 ml α-MEM and plated at a density of 30,000 nucleated cells/cm2, and cultured under 
the same conditions. The culture medium was replaced three times per week and at near 
confluence (90%) the adherent cells were washed with phosphate- buffered saline 
solution and enzymatically detached by means of a 0.25% trypsin-EDTA solution (Sigma, 
St. Louis, MO). Cells were re-plated at a density of 30,000 cells/cm2 and a subsequent 
passage performed 7-10 days after, when cells achieved near confluence.  
 
Viral Vector Production  
 
Vectors encoding Cx43 and BMP-7 were produced by the University of Michigan Vector 
Core employing standard transient transfection methods to produce replication 
incompetent viral vectors.  The development and production of adenovector encoding 
BMP7 under the transcriptional control the human CMV promoter has been previously 
described 50  Similarly the development and production of the lentiviral vector encoding 
Cx43GFP has also been previously described 35.  The latter vector system was based on 
the human immunodeficiency virus Type 1 (HIV-1) and the four plasmids (Rossello et al) 
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required for vector production were kindly supplied by Professor Inder Verma from the 
Salk Institute, San Diego USA.  Empty vectors or vectors encoding GFP were also 
produced for lentivirus (LVGFP, LVMT) and adenovirus (ADCMVMT), as a control 
group for the experiments (Rossello et al). 
 
Transduction of BMSCs  
 
BMSCs were plated at a density of 2.25 million cells per T75 flask after second passage.  
For Cx43-GFP, GFP, and MT transductions, lentiviral vector with a titer of 106 
transducing units/ml was used on day 3-4 of culture. Transduction was carried out in the 
presence of 8 µg/ml of protamine sulfate to enhance the transduction efficiency.  Five ml 
of filtered vector-containing media was added to the cell cultures for approximately 16 h 
(transduction phase), followed by replacing this media with fresh media for 6-8 h 
(recovery phase).  The cells were exposed to three cycles of transduction.  After 12 days 
of incubation, transduced BMSCs cells were examined under fluorescent microscopy to 
determine transduction efficiency through GFP fluorescence. Transductions with 
ADCMVBMP7 and ADCMVMT were done as previously stated.  Briefly, for in-vitro 
transduction of BMSCs, adenovirus at the desired titer to achieve a multiplicity of 
infection of 200 PFU was added to cells in serum-free α-MEM. After 4 h, FBS was added 
to a final concentration of 2% and medium was kept on cells for an additional 24 h.  
 
Calvarial defect surgeries 
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All surgeries were performed in accordance with the University Committee on Use and 
Care of Animals (UCUCA). Animals were housed in a light- and temperature-controlled 
environment and given food and water ad libitum. A sample size of 4 scaffolds per 
condition was determined based on the results of the previous subcutaneous experiments.  
5-week-old female SCID mice (N:NIH-bg-nu-xid; Charles River Laboratories, Raleigh, 
NC, USA) were used for each experiment. Animals were anesthetized with 
intraperitoneal injections of ketamine–xylazine (50 and 5 µg/g, respectively) in saline.  A 
linear scalp incision was made from the nasal bone to the occiput and full-thickness flaps 
were elevated. The periosteum overlying the calvarial bone was resected. A trephine was 
used to create a 5-mm craniotomy defect centered on the sagittal sinus.  The wounds will 
be irrigated with Hanks’ balanced salt solution (HBSS) while drilling. The calvarial disk 
will be removed carefully in order to avoid injury to the underlying dura or brain. After 
careful hemostasis, gelfoam scaffolds (D=5mm, t=0.3mm) previous loaded with cells will 
be placed into the defects (500,000 cells). The scaffolds filled the entire defect and 
attached to the bone edges around the entire periphery.  The incisions were closed using 
4-0 Chromic Gut suture (Ethicon/Johnson & Johnson, Sommerville, NJ) and the mice 
were let to recover from the anesthesia on a heating pad (Kent Scientific).  After 4, 8, and, 
12 weeks, animals were sacrificed and the calvaria was removed for micro CT and 
histological analysis. 
 
Micro-CT 3D image acquisition and analysis  
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Ossicles were scanned on a high resolution cone beam micro-CT system (Enhanced 
Vision Systems (now GE Healthcare Preclinical Imaging), London, Ontario, Canada) 
while immersed in distilled H2O. The x-ray source voltage and current were 80 kVp and 
80µA, respectively. To reduce the potential for beam hardening artifact, the x-rays were 
passed through a 0.2mm Al filter immediately upon exiting the source and the specimens 
were immersed in dH2O during the scanning process. Projection images were acquired 
over 198 degrees using 2x2 binning and an exposure time of 1100 ms, and four frames 
were averaged for each projection to improve the signal to noise ratio. The projection 
data was then corrected and reconstructed using the Feldkamp cone-beam algorithm to 
create three-dimensional images with an isotropic voxel size of 18µm.  The scanner was 
calibrated once daily using a phantom that contained air, water and hydroxyapatite. 
 
Bone volume fractions were determined by using a MatLab program designed to 
integrate all grayscale voxels above a particular threshold.  To determine the overall 
volume of the ossicles, the program determined the perimeter of each 2D µCT slice by 
tracing the outer edge. The program then integrated all the perimeters to determine the 
3D surface area, and the number of voxels inside the surface defined the total volume.  
High density voxels outside of the 3D surface and unattached to the ossicle were 
discarded, while voxels inside were evaluated at the specified thresholds to determine the 
BVF, which was calculated as the number of voxels above the threshold relative to the 
total number of voxels.  A threshold of 1100 was used to quantify the BVF64.   Rendered 
images of the whole calvaria were taken at this threshold to show the regeneration of 
bone on the defect form both an aerial and a sagital perspective.    
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Histology and morphological analyses 
 
Ossicles were removed from the site of the defect in the calvaria.  The ossicles were 
rinsed in water and then decalcified in 10% formic acid for 5 days.  After decalcification, 
the tissues were embedded in paraffin. 5 µm sections were made and placed on 10 slides 
with 3 sections per slide. The tissue was deparaffinized hydrated, and the first, fifth, and 
tenth slides were stained with H & E. Image Pro Plus 4.0 was used to take pictures of the 
histological sections in order to observe the overall bone formation, cortical thickness, 




Cells overexpressing Connexin 43 exhibit increased cell to cell communication and 
differentiation in core regions of the scaffold.  Regeneration of bone was also 
significantly altered both in volume fraction and apparent pattern of osteogenesis.  
Regenerated bone was significantly affected based on GJIC (figure 3).  When cells were 
transduced to overexpress the mutant Cx43∆7, bone regeneration (fig 3a-c, BVF;  4 
week: 6.1+/-1.1, 8 week: 4.8+/-0.9, 12 week: 5.2+/-1.3) was significantly less compared 
to all groups (p<0.001, against all groups).  Furthermore, there was no significant 
difference in regenerated bone between the different time points in cells overexpressing 
the mutant connexin.  Cells overexpressing Cx43 (BVF; 4 week: 21.8+/-6.1, 8 week: 
53.9+/-13.2, 12 week: 46+/-9.5), however, regenerated larger tissue equivalents of bone 
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than BMSCs alone ((BVF; 4 week: 21.8+/-6.1, 8 week: 53.9+/-13.2, 12 week: 46+/-9.5) 
at all time points (p(4 weeks) =0.012, p(8 weeks)<0.001, p(12 weeks)<0.001).   
 
Cells overexpressing BMP7 also exhibited larger volume fractions of regenerated bone 
when GJIC was enhanced (figure 3p).   The cotransduced group regenerated significantly 
more bone than groups with BMP7 alone in the critical sized defect region.  However, 
when cells overexpressed BMP7 only, large volumes of bone were regenerated outside 
the region of the defect (figure 3j-l), that are not observed in cotransduced cells (3m-o).  
 
Further qualitative depiction of regenerated bone was obtained through histological 
analysis (figure 4) in the interface between the calvaria and the tissue engineered bone.  
Cx43∆7 overexpressing group exhibits no bone regeneration, with undifferentiated cells 
still entrapped in the gelatin scaffold (figure 4a).  BMSC-regenerated bone is non-
continuous, although some bone is regenerated, containing entrapped cells and some 
marrow (fig 4b).  When Cx43 is overexpressed, the bone tissue is continuous, with 
entrapped cells, no marrow cavity is present and, it is contained within the region of the 
defect (fig 4c).  The presence of BMP7 in BMSCs enabled regeneration of bone with full 
marrow cavity, encapsulated with a thin layer of bone containing entrapped cells (fig 4d). 
Some trabecular bone is observed and the regeneration of bone extends further outside 
the region of the defect.   Interestingly, such large amounts of regenerated bone outside 





Figure 1:  Increased GJIC increases bone volume fraction of critical sized mouse calvarial defects.  
Rendered images of aerial (top) and sagital (bottom) views defect sizes (a-o) show the level of 
GJIC enhanced or inhibited the bone volume fraction.  Cx43 overexpression exhibits larger 
distribution of bone healing, relative to the BMSCs group at all time points.   The same is 
observed when these groups are also treated with BMP7, where the co transfected group 
produced large coverage over the defect site at all time points.   Deletion mutants (Cx43∆7) 
exhibited little bone healing in the defect site.  To quantify these observations, the BVF is 
determined (b).   Groups overexpressing Cx43 exhibited significant increases in BVF over their 
control groups.  In this case of the co-transformation, the healing of the defect is maximized over 
all other groups in the 4th and 12th week (b).  Deletion mutants were characterized by low BVF 




Figure 2: Histological sections of 12 week transplants showing the interface between calvaria and 
new bone formation.  Cx43∆7 ossicles are characterized by little or no bone formation in the 
interface between the ossicle and calvaria (a). Overexpression of Cx43 (b) produces more of a 
continuous cortical-like bone formation throughout the defect, compared to that generated by 
BMSCs (c).  Expression of BMP7 increased healing with the periphery (d, e), and the effect of 
Cx43 with BMP7 was to produce bone regenerates that were more specific to the defect size (e), 
compared to a larger bone ossicle with complete bone marrow cavities produced by the BMP7 
only ossicles. Red boxes indicate the interface site between ossicle and calvaria. 
 
 
